Multi-lumen catheter with separate distal tips

Information

  • Patent Grant
  • 9387304
  • Patent Number
    9,387,304
  • Date Filed
    Thursday, July 10, 2014
    9 years ago
  • Date Issued
    Tuesday, July 12, 2016
    7 years ago
Abstract
A multi-lumen catheter including a generally cylindrical body enclosing a first and second lumen separated by a generally planar septum. A first and second tip section extend from a distal end of the body. The first and second tip section may each include a generally planar surface. The second tip section may include a first segment extending from the distal end of the body to a transition segment and a second segment extending from the transition segment to a distal end of the second tip section.
Description
FIELD OF THE INVENTION

The present invention relates generally to a multi-lumen catheter having a plurality of separate distal tips and more particularly to an improved split-tip catheter.


BACKGROUND OF THE INVENTION

Multi-lumen catheters are used for the purpose of creating two or more separate fluid pathways, such as in hemodialysis applications. A primary goal of hemodialysis access is to provide a reliable and effective means of dialysis, which means that a sufficient volume of blood over a period of time must be removed from and returned to the patient. Because the contaminated and cleansed blood must be kept separate for an effective dialysis procedure, a dual lumen catheter is generally used. These dual lumen catheters are usually configured so that there is a shorter lumen that aspirates blood from a blood vessel of a patient to a dialysis machine where it is processed for the removal of toxins, and a longer lumen that infuses the purified blood to the patient. The shorter lumen utilized for aspiration is generally referred to as the “arterial lumen,” while the longer lumen utilized for infusion is generally referred to as the “venous lumen.” The reason for the different lengths is to minimize co-mingling of aspirated and infused blood.


The primary problems occurring in dual lumen dialysis catheters are blood clotting (thrombosis) and fibrin (the protein formed during normal blood clotting that is the essence of the clot) sheath formation. Thrombus and fibrin sheath formation can occlude distal tips of the dialysis catheter lumens, resulting in loss of catheter function when such an occlusion prevents blood flow. This typically occurs initially in the arterial lumen used for aspiration of blood from a patient. A secondary problem relates to the arterial lumen “sucking” against the vessel wall, in which the arterial lumen openings become fully occluded by the patient's vasculature.


To specifically address these problems, a new type of dialysis access catheter has been designed that utilizes independent “free floating” distal tip sections that separate at a distal end of the catheter to theoretically reduce the likelihood of potential occlusion and “sucking” during dialysis treatment. U.S. Pat. No. 6,001,079 to Pourchez and U.S. Pat. Nos. 5,947,953 and 6,190,349 to Ash et al., all incorporated by reference herein, are directed to said new type of catheter, hereinafter referred to as a “split-tip catheter.”


Catheters used for hemodialysis are generally inserted according to standard technique. This includes identifying the location of the central veins in which the catheter is to be inserted, utilizing the Seldinger technique to cannulate the central vein with a guidewire, and passing various instruments over the guidewire until the catheter is in place. In the case of a small diameter catheter made of relatively stiff material (i.e., a percutaneous catheter for acute access), the catheter itself can be passed over the guidewire and into the central vein. In the case of a larger diameter catheter, the passage to the central vein must be widened through the use of dilator(s), after which the catheter can be passed over the guidewire. Another possibility available to the physician is to use an introducer sheath, which is passed over the guidewire (after dilation or simultaneously therewith) forming a path for the catheter to access the central vein.


Due to the configuration of the split-tip catheter, standard insertion techniques must be modified. With respect to non-sheath insertions, the separate distal tip sections must each be passed over the guidewire to ensure their arrival at the targeted central vein without attendant problems. Suggested means for accomplishing this (in a dual lumen catheter) is to pass the back end of the guide wire through the distal end hole of one tip section and out a side hole thereof into the distal end hole of the other tip section (Patel et al., J. Vasc. Interv. Radiol. (2001), vol. 12, pages 376-378). However, such a method can become problematic depending on the placement of the side holes and, in fact, may be impossible in the event that no side holes are provided. With respect to sheathed insertions, the separate distal tip sections may tend to flare outward and catch or “snag” on the inner wall of the delivery sheath thereby preventing smooth delivery of the catheter to the central vein.


There is a need for improvements to split-tip catheters and new configurations thereof, which enhance the design and further alleviate concerns with regard to typical problems encountered in hemodialysis catheters. There is also a need for new configurations and new methods for insertion of split-tip catheters to overcome problems associated therewith


SUMMARY OF THE INVENTION

In accordance with the present invention, several embodiments are described, which may be improvements to prior art split-tip catheters or may be novel catheter embodiments heretofore undisclosed. As used herein, the following terms have the following meanings:


“Split-tip catheter” refers to a catheter having a body enclosing at least two lumens and a dividing point that separates at least two tip sections from one another distal thereto, each of the tip sections enclosing at least one lumen and being separated or separable from one another along their length.


“Dividing point” refers to a point along the length of the split-tip catheter distal to which at least two tip sections are separated or are separable from one another.


“Tip section” refers to a portion of the split-tip catheter, enclosing at least one lumen, which is separable or is separated from another tip section along its length distal to a dividing point.


“Inner surface” refers to a surface on a tip section that is facing or adjacent a companion tip section (a tip section that separates or is separable distal to the same dividing point).


“Outer surface” refers to a surface on a tip section that is not facing a companion tip section.


“Separation force” refers to a force required to separate the tip sections from one another.


“Excessive separation force” refers to a force required to separate the tip sections from one another, which is too great to be considered practical for a clinician in a typical setting. By definition, an excessive separation force is required to separate the tip sections of the split tip catheter from one another proximal to the dividing point.


“Cylindrical” is used according to its ordinary meaning (i.e., a shape having a constant circular cross-section).


One improvement to prior art split-tip catheters comprises a unique configuration of each tip section to improve flow characteristics, provide ease of delivery and overcome typical problems associated with hemodialysis catheters. In a dual lumen embodiment, the split-tip catheter comprises a shorter arterial tip section comprising a semi-cylindrical shape with a rounded distal end, and a longer venous tip section comprising a semi-cylindrical shape in a proximal portion which smoothly transitions in a transition region to a cylindrical shape in a distal portion, the cross-sectional size of the distal portion being greater than the cross-sectional size of the proximal portion, the distal portion terminating in an inward bevel. Another improvement comprises the strategic placement of openings placed on the tip sections of the split-tip catheter. With particular respect to an arterial tip section in a dual lumen configuration, the openings are offset both longitudinally and circumferentially so that full 360° fluid flow is realized and problems related to “sucking” against the vessel wall are mitigated.


Another improvement to the prior art split-tip catheters comprises a means for reducing dead space on the surface of the tip sections of a split-tip catheter in the region of separation, which includes, but is not limited to, an opening or openings located on an inner surface of one or more tip sections near a dividing point of the split-tip catheter. In one embodiment of the invention, a hole or opening is positioned on an aspirating lumen tip section. In another embodiment of the invention, a hole or opening is positioned on an infusion lumen tip section. In each of these embodiments, there could be multiple holes or openings on the lumen tip sections. Additionally, the hole(s) or opening(s) could be positioned in many different locations along the length of the tip sections and/or catheter.


An additional improvement to prior art split-tip catheters is related to the delivery thereof either with or without the use of a delivery sheath. With respect to a non-sheathed delivery, the improvement concerns strategic placement of a guidewire opening in the distal end of the venous tip section so that the guidewire is easily passed through the venous tip section and into the arterial tip section. With respect to a sheathed delivery, the improvement relates to a friction-reducing means for reducing friction between the catheter and a delivery sheath. As discussed above, movement of the delivery sheath with respect to the split-tip catheter can result in the inside surface of the delivery sheath engaging the tip sections, which can cause tears in the delivery catheter, problems in the delivery process and other unwanted occurrences.


Thus, in one embodiment of the invention, a bump or protrusion of material is positioned on the outer surface of one or more tip sections adjacent the inside surface of the delivery sheath. In another embodiment of the invention, a ring of material is positioned around the end of one or more tip sections. In yet another embodiment of the invention, an inflatable material is positioned on the outer surface of the catheter in one or more locations to be inflated during delivery to provide a buffer zone for prevention of direct contact of the tip sections with the inside surface of the delivery sheath. Following delivery of the split-tip catheter, said material would be deflated. In still another embodiment, bumps or protrusions of material are positioned on the inside surface of the sheath.


With respect to prior art split-tip catheters that are releasably joined or “splittable,” an improvement is described in which tip sections that are initially joined together distal to a dividing point can be separated along a predetermined length thereof upon an application of a particular separation force. In this aspect of the invention, the separation force required to disjoin the tip sections varies along the length of the tip sections (in the described embodiments the separation force increases from the distal end to the proximal end of the catheter) as the bond between the tip sections is varied.


Thus, in one embodiment, the splittable tip sections are releasably joined to one another distal to a dividing point, enabling split and joined configurations to be interchangeable. In another embodiment of the invention, the bond between the splittable tip sections varies in a continuous fashion along their length in such a way that the force required to separate them is progressively increased in a straight line fashion as measured from a distal end of the tip sections to the dividing point. In yet another embodiment of the invention, the required separation force increases in incremental steps as measured from a distal end of the tip sections to the dividing point. In each of these embodiments, while the tip sections are splittable along a predetermined length of the catheter distal to a dividing point, it should be appreciated that said dividing point is a fixed point beyond which separation can not take place without use of excessive separation force.


These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a split-tip catheter according to the present invention.



FIG. 2 is a perspective view of an alternate embodiment of a split-tip catheter according to the present invention.



FIG. 3 is a close-up view of the tip sections of the split-tip catheter of FIG. 1, illustrating the positioning of openings therein.



FIG. 4 is a similar view to FIG. 3, illustrating an alternate embodiment thereof.



FIG. 5 is a perspective view of a straight version of a split-tip catheter according to the present invention.



FIG. 6 is a perspective view of a precurved version of a split-tip catheter according to the present invention.



FIG. 7 is a close-up view of the distal end of the split-tip catheter of FIGS. 5 and 6.



FIGS. 8A-8G are cross-sectional views of the distal end of the split-tip catheter of FIG. 7, taken along lines 8A-8A, 8B-8B, 8C-8C, 8D-8D, 8E-8E, 8F-8F, 8G-8G, respectively.



FIG. 9 is a perspective view of FIG. 7 taken along line 9-9.



FIG. 10 is a cross-sectional view of FIG. 9, taken along line 10-10.



FIGS. 11A-11E are cross-sectional views of FIG. 10, taken along lines 11A-11A, 11B-11B, 11C-11C, 11D-11D, 11E-11E, respectively.



FIG. 12 is an alternate embodiment of the split tip catheter of the present invention, showing a close-up view of a distal end thereof.



FIG. 13 is a perspective view of FIG. 12 taken along line 13-13.



FIG. 14 is a cross-sectional view of FIG. 13, taken along line 14-14.



FIG. 15A is an inside view of an introducer sheath containing a prior art split-tip catheter.



FIG. 15B is a close-up view of the prior art catheter of FIG. 15A, showing forces acting thereon upon delivery out of the introducer sheath.



FIG. 16 is a perspective view of the tip sections of a split-tip catheter according to one embodiment of the present invention.



FIG. 17 is a perspective view of the tip sections of a split-tip catheter according to another embodiment the present invention.



FIG. 18 is a perspective view of the tip sections of yet another embodiment of a split-tip catheter according to the present invention



FIG. 19 is an inside view of an introducer sheath according to one embodiment of the present invention.



FIG. 20 is a cross-sectional view of FIG. 11 taken along line 20-20.



FIG. 21A is a graph illustrating a continuous separation force F as a function of position P of the tip sections.



FIG. 21B is a graph illustrating an incremental separation force F as a function of position P of the tip sections.



FIG. 21C is a representative view of a split-tip catheter, showing one embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21D is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21E is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21F is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21G is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21H is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 21I is a representative view of a split-tip catheter, showing another embodiment of the present invention regarding varying separation force required to separate the tip sections.



FIG. 22A is a representative view of a split-tip catheter, illustrating a twisted configuration according to one embodiment of the present invention.



FIG. 22B is a representative view of a split-tip catheter, illustrating a twisted configuration according to another embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention.


The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.


The present invention is directed to multi-lumen catheters with separate distal tips in the form of improvements over prior art split-tip catheters as well as new configurations and embodiments. While the examples and embodiments of a multi-lumen catheter are discussed herein in terms of a dialysis catheter, it should be appreciated that there are many other possible uses for a multi-lumen catheter of the type presented herein. Also, while a currently preferred material is medical grade polyurethane, it should be appreciated that a variety of suitable materials could be utilized to form the multi-lumen catheter of the present invention. Importantly, the material chosen should possess characteristics such as flexibility, durability and relative softness and conformability when placed within a blood vessel.


Referring now to FIG. 1, a split-tip catheter 10 is shown having a proximal end 12 and a distal end 14. The proximal end of the catheter 12 is attached to a Y-connector 60, which in turn is connected to extension tubing 62, as is standard in dialysis catheters. The catheter 10 has two lumens defined by an outer wall 16 and a bisecting planar septum 18. The two lumens extend from the proximal end of the catheter 12 to the distal end of the catheter 14 and have a D-shape configuration due to the planar septum 18. Of course, this is not the only possible configuration and certainly the lumens could assume a variety of shapes, including circular, crescent-shaped, oval, etc. The Y-connector 60 and extension tubing 62 fluidly connect the lumens to a blood treatment unit or dialysis machine (not shown). The distal end 14 of the catheter 10 is separated into tip sections 40 and 50 distal to a dividing point 30. While only two tip sections are shown in FIG. 1, it is certainly possible for a plurality of tip sections to branch from the dividing point 30, depending, for example, on the number of lumens within the catheter 10. Thus, it is contemplated that three, four or more tip sections could separate or be separable distal to the dividing point 30, corresponding to three, four or more lumens within the catheter 10.


In addition, although only one dividing point is illustrated in FIG. 1, it is contemplated that two or more could be utilized, which is shown as an alternate embodiment in FIG. 2. A multi-lumen catheter 80 has a first tip section 82 and a second tip section 84 distal to a first dividing point 81 and a third tip section 86 and a fourth tip section 88 distal to a second dividing point 85 distal to the first dividing point 81 along the second tip section 84. Of course, it would be possible to have additional dividing points and tip sections, which could accommodate any number of multi-lumen configurations. Referring back to FIG. 1, the two lumens of the catheter 10 continue from the proximal end 12 to the distal end 14 into respective tip sections 40 and 50 distal to the dividing point 30. The lumens can be of equal size and shape from proximal to distal end or can vary in one or more locations. Thus, for example, if it was desirable to increase the flow of blood, the lumen in tip section 50 could increase in cross-sectional area distal to the dividing point 30 so that blood flowing out of tip section 50 would have a reduced velocity.


Referring now to FIG. 3, the cross-sectional shape of the lumen within tip section 50 transitions from a D-shape to a circular shape, the transition occurring distal to the end opening 44 of tip section 40. Such a configuration for the tip section 50 is optimal for many reasons, which will be explored below with reference to FIGS. 7-14. Importantly, the overall configuration for the distal end 14 of the catheter 10, including the shape of tip sections 40 and 50, has been found to be optimal regarding delivery of the catheter into a body lumen as well as with respect to its performance in vivo.


As shown in FIGS. 1 and 3, tip section 40 terminates in a rounded configuration and tip section 50 terminates in a beveled configuration, providing end openings 44 and 54 therethrough. While certainly there are many possible degrees of angles that can be used for the bevel cut according to the present invention, the currently preferred range is between approximately 25° and 75°, while the angle shown is approximately 45°. Of course, there are a multitude of end configurations possible for each tip section in addition to those shown, including blunt, tapered, curved, notched, etc. In particular, a reverse bevel or notched (area removed from the end) configuration could be formed in the tip section 40 to minimize the opportunity for “sucking” against the wall of the superior vena cava or right atrium during a dialysis procedure. As is standard for dialysis catheters, tip section 40 is used to aspirate blood from the patient, while tip section 50 is used to infuse treated blood from a dialysis machine, as discussed above.



FIG. 3 illustrates one of the stated improvements over the prior art split-tip catheters, namely the presence of an opening in close proximity to the dividing point, by showing the tip sections of FIG. 1 in more detail. Tip sections 40 and 50 distal to dividing point 30 have inner surfaces 45 and 55 and outer surfaces 47 and 57 respectively. In close proximity to the dividing point 30 on inner surface 45 is positioned an opening 46, providing an additional inlet on the tip section 40 for the aspiration of blood. Importantly, opening 46 addresses an apparent problem with certain split-tip catheter designs with respect to clotting and fibrin sheath formation at or near the dividing point. This phenomenon is likely due to the unused surface area proximal to the arterial and venous end openings 44 and 54, which increases the surface area for platelet adhesion. By positioning opening 46 in close proximity to the dividing point 30, blood flow therethrough acts to dislodge any clot formation on the inner surfaces 45 and 55. In addition, the presence of one or more openings in close proximity to the dividing point may permit slow leaching of heparin along the inner surfaces 45 and 55, which also would prevent clot formation as the catheter lumens are flushed between dialysis treatments. As used herein, the term “close proximity” refers to a distance that is nearer the dividing point than the distal end of the subject tip section and can refer to any point along the length of the subject tip section in that range.


It should be appreciated that even though one hole on inner surface 45 is shown in FIG. 3, a plurality of openings are also possible and may even be preferable, depending on the particular application. In addition, although a small circular opening 46 is shown, certainly other shapes and sizes would be equally within the scope of the invention, including oval shapes, slits, etc. For example, an opening near the dividing point could comprise a valve such as that described in U.S. Pat. No. 4,549,879 to Groshong et al., which is incorporated by reference herein. By utilizing a valve, leaching may be controlled, which could be advantageous in certain situations, depending on the patient's disposition. In an alternate embodiment, small mounds of material or protrusions 49 are positioned adjacent the opening 46 on either side thereof as shown in FIG. 4. Of course, while two protrusions 49 are shown, certainly any number of protrusions 49 are contemplated. The protrusions 49 serve at least two purposes, including maintaining separation between the tip sections 40 and 50 and preventing opening 46 from becoming occluded.


While the embodiment shown in FIG. 3 illustrates opening 46 on inner surface 45, it may instead be preferable to place one or more openings on the inner surface 55 of tip section 50. Alternatively, it may be desirable to place one or more openings on both inner surfaces 45 and 55 at similar positions or offset from one another. Similar arrangements are also contemplated with respect to the presence of an opening or openings near the dividing point in catheters having more than two tip sections or more than one dividing point as discussed above, as well as with respect to the use of protrusions near or around the openings. In a split-tip catheter having tip sections that are releasably joined, an opening or openings could be placed at intervals along the length of at least one of the tip sections on an inner surface thereof.


Both tip sections 40 and 50 may include side hole(s) 48 and 58 respectively, positioned near their terminal end for enhanced fluid flow into and out of the tip sections 40 and 50. As should be appreciated by one of skill in the art, many embodiments with respect to the side hole(s) are possible, including an embodiment with no side holes. The side hole(s) 48 and 58 can be positioned at various locations around the circumference of the tip sections 40 and 50 and can be one or several in number. As shown in the embodiment of FIG. 3, tip section 50 has one side hole 58 in the side thereof, while tip section 40 has four side holes spaced in different locations around its circumference and offset lengthwise from the end opening 44. This particular configuration will be explored below in reference to FIGS. 7-8.



FIGS. 5-11 illustrate an embodiment of the split-tip catheter of the present invention similar to that depicted in FIG. 1. FIG. 5 depicts a straight configuration of a split-tip catheter 100, while FIG. 6 depicts a precurved configuration thereof. In each instance the split-tip catheter 100 includes a flexible cylindrical catheter tube 114 that encloses a pair of distinct lumens. In the precurved configuration in FIG. 6, a medial portion of the catheter tube 114 is formed into a bend 116. The distal end 128 of the split-tip catheter 100 is bifurcated into a pair of distal tip sections 124, 126, which are distal to a dividing point as discussed above. Each of the tip sections 124, 126 enclose a lumen that is respectively continued from the pair of distinct lumens enclosed in the catheter tube 114.



FIGS. 7-8 illustrate the distal tip sections 124, 126 in greater detail. As seen in FIG. 8A, the catheter tube 114 encloses substantially similar D-shaped lumens 120, 122 separated by a planar septum 118. These lumens 120, 122 continue on into the distal tip sections 124, 126 respectively, the lumen 120 and associated tip section 124 being the shorter arterial lumen and tip section that is used to withdraw blood from the cardiovascular system for dialysis treatment outside the body, and the lumen 122 and associated tip section 126 being the longer venous lumen and tip section that is used to return blood to the cardiovascular system following said dialysis treatment. The arterial tip section 124 has a planar surface 130 which faces and is adjacent to a planar surface 132 of the venous tip section 126, each of the planar surfaces 130, 132 being extensions of the planar septum 118 distal to the dividing point.


Similar to the embodiment shown in FIG. 1, the distal arterial tip section 124 terminates in an end opening 134 that assumes a semicircular profile when viewed from the side (FIG. 7). While the lumen 120 is D-shaped and continues through the end opening 134 as such (i.e., the lumen 120 does not taper or enlarge), the side view shows a semicircular profile due to the edges of the distal end of the arterial tip section 124 being rounded. This rounding can be seen in greater detail in FIGS. 3 and 4 as well as in FIG. 9, which illustrates a view from the side of the arterial tip section 124 identified by line 9-9 in FIG. 7. As shown, an edge 133 of the distal end of the arterial tip section 124 assumes a scalloped configuration as a result of the rounding process. Such rounding is accomplished by heating with radio frequency (RF) energy, although certainly many other methods of heating could be utilized, but is not limited to the distal end of the arterial tip section 124. Indeed, rounding of the split-tip catheter 100 can be employed on various edges and ends thereof.


As mentioned, the D-shape of the arterial tip section 124 is unchanged along the full length thereof, having planar surface 130 and a semicircular surface 135 that interconnects rounded corners 136 and 137 at the lateral ends of the arterial tip section 124 (see FIGS. 8B-8E) and having an end opening 134 as explained above. Arterial tip section 124 also has four additional openings for withdrawing blood and for maintaining patency of the lumen 120 and arterial tip section 124 in the event that the end opening 134 is somehow blocked, the four openings being strategically placed in a longitudinal and circumferential pattern for maximum effect. Specifically, opening 141 can be seen in FIG. 9 (and FIG. 8E), just proximal to the end opening 134 in the semicircular surface 135, while FIGS. 8B-8D show openings 138, 139 and 140.


In FIG. 8B, opening 138 is through the planar surface 130 of arterial tip section 124, to provide a pathway for blood flow between the arterial and venous tip sections 124, 126, thereby reducing blood stagnation between the tip sections as discussed above in connection with FIGS. 3 and 4 (showing openings adjacent the dividing point 30). Opening 138 is positioned at a longitudinal location proximal to opening 141. FIGS. 8C and 8D show openings 139 and 140 respectively through the corners 136, 137. These side or corner openings 139 and 140 are offset as can be appreciated from FIG. 7, opening 139 being positioned at a longitudinal location proximal of opening 140, each of which openings are proximal of opening 141. As depicted, the openings are approximately equidistant from one another, or more precisely, the distance between each consecutive opening 138-141 in the arterial tip section 124 is substantially the same. It should be specifically noted that side openings 139 and 140 are multi-planar in nature having portions formed through adjacent sides of the catheter (i.e., planar surface 130 and semicircular surface 135). The multi-planar aspect of the side openings 139 and 140 is particularly advantageous with respect to prevention of occlusion of the arterial lumen due to the remote possibility that either of the openings could be completely obstructed by a vessel wall.


The positioning of the openings 138-141, as well as the distance therebetween, is very important with respect to the stated goals of facilitating blood flow and maintaining patency of the catheter. By positioning each opening at longitudinal locations offset from one another (and in this case approximately equidistant from one another) as well as at different points around the circumference of the arterial tip section 124, alternative flow through the arterial tip section 124 is permitted, preventing thrombus and fibrin formation as well as “sucking” against the vessel wall. More specifically, the offset positioning on four different sides enables 360° multi-planar flow into the arterial tip section 124 with five effective sides (including the end opening 134) for the receipt of blood, such that total occlusion of the arterial tip section 124 is largely eliminated.


The distal venous tip section 126 comprises a proximal portion 142, a transition region 143 and a distal portion 144. The proximal portion 142 has a semicircular cross-section similar to the arterial tip section 124 that is unchanged from the dividing point to the transition region 143 as can be appreciated by viewing the cross-sections shown in FIGS. 8B-8E. The planar surface 132 of the venous tip section 126 forms a planar outer wall of the proximal portion 142 on the side of the venous tip section 126 adjacent to the arterial tip section 124 as explained above. A semicircular wall 145 interconnects the lateral ends of the venous tip section 126 to complete an enclosure of the venous lumen 122. As with the arterial lumen 120, venous lumen 122 is the same size as its counterpart in the catheter tube 114, although as mentioned above many variations are possible.


The transition region 143 connects the proximal portion 142 to the distal portion 144 and comprises a transition shoulder 156. The transition region 143 continuously changes in cross-sectional shape along its length in transitioning from the semicircular shape of the proximal portion 142 to the circular shape of the distal portion 144. As shown, the transition shoulder 156 is positioned on a side of the venous tip section 126 adjacent the arterial tip section 124, although certainly other configurations are possible with respect to positioning of the transition shoulder. In addition, configurations including multiple transition shoulders are contemplated herein.


The shape of the venous lumen 122 transitions from a D-shape in the proximal portion 142 to a circular shape in the distal portion 144, although the actual cross-sectional area of each shape can be manipulated to accommodate the particular application (i.e., the cross-sectional area of the distal portion with respect to the proximal portion can increase, decrease or remain substantially equivalent). In one embodiment, the cross-sectional area for the venous lumen 122 in the distal portion 144 of the venous tip section 126 is standardized to permit all sizes of the catheter to be tunneled subcutaneously during implantation using a single size of tunneling trocar. Thus, the cross-sectional area of the lumen 122 in the proximal portion 142 of the venous tip section 126 (as well as the cross-sectional area of the proximal portion 142 itself) would vary depending on the size of the catheter. One possibility, therefore, would include an increase in cross-sectional area of the venous lumen 122 from the proximal portion 142 to the distal portion 144 of the venous tip section 126. This could have advantages in that the discharge velocity of fluid flowing out of the end 146 would be reduced, translating into less trauma to the vessel and minimized effects related to shear stress. Of course, it should be apparent to one of skill in the art that various combinations of cross-sectional shapes and sizes for the venous lumen 122 are possible along the length thereof, each of which could enjoy certain advantages and benefits.


The distal portion 144 has a cylindrical shape with an open end 146 that is inwardly beveled in the proximal direction toward a plane P132. End opening 148 through the open end 146 is contained in a plane P148 that is shown in FIG. 7 as being oriented at a bevel angle A146 to plane P132. As a result of the bevel, the end opening 148 is necessarily oval shaped. The bevel angle A146 is shown as approximately 45°, although as stated above in connection with FIGS. 1 and 3, certainly many other angles are possible, the preferred range being between approximately 25° and 75°. The open end 146 of the venous tip section 126 is rounded (represented by the double line in FIGS. 7 and 9) similar to the end of the arterial tip section 124. Referring to FIGS. 8F and 8G, the distal portion 144 of the venous tip section 126 contains two openings 150 and 152 that are longitudinally offset from one another. As with the various openings described above, openings 150 and 152 can be provided in different shapes and sizes and can be positioned at various points along the venous tip section 126 to provide additional outlets for the flow of blood in the event that a blockage occurs.



FIG. 9 is a view of the distal end 128 of the split-tip catheter 100 perpendicular to plane P132 identified in FIG. 7 by line 9-9. FIG. 10 is an enlarged longitudinal sectional view of the venous tip section 126 taken along line 10-10 in FIG. 9, illustrating the transition region 143. Various transverse cross-sectional views of venous tip section 126 taken along various lines in FIG. 10 are shown in FIGS. 11A-11E. Taken together, FIGS. 9-11 reveal that in transition region 143 a shoulder 156 of continuously longitudinally varying width and height projects outwardly from the planar surface 132 of proximal portion 142. Referring to FIG. 9 along with FIGS. 11B-11D, it can be seen that the transition shoulder 156 has a semicircular cross-sectional aspect with a width and a height above the planar surface 132 that increase from the proximal portion 142 to the distal portion 144 such that shoulder 156 is equal to the outer diameter of the distal portion 144 at the distal end thereof.


In FIG. 9, shoulder 156 is shown as having linear lateral boundaries 160 at which the exterior surface of the shoulder 156 emerges from the planar surface 132 of venous tip section 126. The lateral boundaries 160 intersect at a proximal end 158 of the shoulder 156 and are symmetrically disposed on opposite sides of the longitudinal axis L128 of the distal end 128 of the catheter 100. While a specific configuration for a transition shoulder is described above, it should be understood that other configurations are possible and are contemplated herein, including, for example, a transition shoulder that decreases in width from the proximal portion 142 to the distal portion 144. In any case, the slope of the shoulder 156 should be positive, although it can be formed with varying degrees with respect to plane P132. Thus, although a positive slope of approximately 5° is shown in FIG. 10, certainly many other possibilities exist that would be within the scope of the invention.


The shoulder 156 is penetrated obliquely by a somewhat longitudinally-aligned guidewire aperture 162 that communicates between the exterior of the venous tip section 126 and the venous lumen 122 in transition region 143 and distal portion 144. As clearly seen in FIG. 7, the guidewire 164 is shown extending from arterial lumen 120 through the open end 134 of arterial tip section 124 and through a guidewire aperture 162 in the transition shoulder 156 into the venous lumen 122 of the venous tip section 126, thereby seamlessly connecting the two lumens and tip sections. While threading a guidewire through adjacent tip sections has been preliminarily explored in the prior art, the embodiments disclosed herein are advantageous for several important reasons. For example, the configuration of the tip sections with respect to one another in combination with a transition shoulder having a positive slope and having a guidewire therethrough affords a streamlined approach to connecting the tip sections for ease of delivery to a targeted lumen. In addition, the particular configuration of the inner wall of the guidewire aperture imposes minimal binding stresses on an insertion guidewire, making the split-tip catheter freely slidable thereon.


Although the examples herein with respect to a guidewire aperture are discussed in terms of passage of a guidewire therethrough, it will be appreciated by one of skill in the art that an aperture could also be configured for passage of a stylet or other instrument, such as the applicator discussed in U.S. Pat. No. 5,405,341 to Martin, which is incorporated by reference herein. Assuming a larger diameter for a stiffening stylet when compared to a standard guidewire, such an aperture would tend to be greater in size than the described guidewire aperture, although certainly many sizes and shapes are possible, including slits.


Referring to the transition shoulder 156 as seen in FIGS. 9-11, the guidewire aperture 162 is formed therein, which is bound by an encircling interior wall 163 that has an inner periphery 165 and an outer periphery 166. The interior wall 163 defines an open cylindrical space through the transition shoulder 156 and has a longitudinal central axis L163. The guidewire aperture 162 is formed through the wall of the transition shoulder 156 at the point through which it is formed at an angle A162, which is the measurement between plane P132 and longitudinal axis L163. This angle facilitates free slidability of the guidewire through the arterial and venous tip sections 124, 126. It is important to note that many different values for angle A162 can be provided, which should equally result in the desired slidability with respect to an insertion guidewire. In particular, it has been discovered that angles (as measured between plane P132 and longitudinal axis L163) within the range of approximately 0° to 80° provide the desired functionality, with the optimum range being approximately 0° to 45°. The guidewire aperture 162 should be large enough to accommodate passage of a standard 0.038 inch guidewire, but not so large as to permit significant back flow of blood therethrough. In particular, with respect to a 0.038 inch guidewire, it has been discovered that an opening having a radius in the range of approximately 0.039 inch to 0.050 inch is sufficient to allow passage while minimizing unwanted back flow, with the optimum range being approximately 0.039 inch to 0.041 inch. Certainly, however, other radius possibilities exist and would be within the scope of the invention.


In implanting the split-tip catheter 100, the insertion guidewire 164 is threaded into the catheter 100 by first passing the proximal end thereof into end opening 148 of the venous tip section 126 and along the venous lumen 122 within the distal portion 144, through the guidewire aperture 162 and into the end opening 134 of the arterial tip section 124 where it is advanced along the full length of arterial lumen 120 to exit the catheter tube 114 at a proximal end thereof. This course taken by the guidewire 164 is shown in FIG. 7. During implantation into a target vessel, the distal end 128 of the split-tip catheter 100 is slid in a distal direction along guidewire 164 to a desired location, the guidewire having been previously extended thereto.


In another embodiment of the present invention, a guidewire lumen is formed through the distal portion of the venous tip section, but is separate from the venous lumen. Thus, in this embodiment the distal portion of the venous tip section comprises two lumens whereas the proximal portion of the venous tip section comprises only one. This would be possible, for example, by providing a transition region similar to that shown in FIG. 7, where the size of the venous tip section increases from proximal to distal portions. In such a configuration, the venous lumen could remain approximately the same size from the proximal to distal portions with the additional cross-sectional size of the distal portion of the venous tip section being utilized for an additional lumen therethrough. The additional lumen ideally would be positioned at a location in the venous tip section closest in proximity to the arterial tip section (i.e., above the venous lumen in reference to FIG. 7) so that an instrument passing therethrough will have to bend only slightly or not at all when passing out of the arterial tip section and into the venous tip section.


The presence of an additional lumen permits the use of a stiffening stylet as described above, without having to increase the size of the guidewire aperture (which may be advantageous to avoid excessive loss of blood therethrough). Thus, the described embodiment could be formed with or without a guidewire aperture. In the case that a guidewire aperture was not formed through the transition region, the additional lumen could accommodate a guidewire, stiffening stylet or both (in addition to possible other medical instruments). In the case that a guidewire aperture is formed through the transition region, a guidewire and stiffening stylet could be used simultaneously if so desired.


An alternate embodiment of the present invention with respect to the configuration of the tip sections is provided in FIGS. 12-14. A split-tip catheter 200 is shown having arterial tip section 224 and venous tip section 226 in FIG. 12, the arterial tip section 224 having a planar surface 230 extending from a dividing point and venous tip section 126 having a planar surface 232 in facing relation thereto. Planar surfaces 230, 232 extend from a planar septum 228, which divides a catheter tube 214 into a pair of distinct lumens that continue into the arterial tip section 224 and the venous tip section 226 respectively distal to the dividing point. Arterial tip section 224 has a terminal end that is cut perpendicular to a longitudinal axis thereof through which an end opening 234 is formed. Arterial tip section 224 contains three additional openings spaced approximately 120 degrees from one another around the circumference of the arterial tip section 224, which are offset longitudinally approximately equidistant from one another. Openings 238 and 240 can be seen in FIG. 13, while the third opening is positioned through the planar surface 230 of the arterial tip section 224.


The venous tip section 226 has a proximal portion 242, a transition region 243 and a distal portion 244 and has an end 246 with an opening 248 therethrough (see FIG. 13). Similar to the above-described embodiment, venous tip section 226 has two openings on opposite sides of the distal portion 244, of which opening 252 is shown in FIG. 12. These openings are offset longitudinally along the length of the distal portion 244. The proximal portion 242 has a cross-sectional semicircular shape, while the distal portion 244 has a cross-sectional cylindrical shape. The transition region 243 increases in width and height in a distal direction moving from the proximal portion 242 to the distal portion 244. The transition region 243 includes a pair of longitudinally extending, parallel reinforcing ridges 254, 256 (FIG. 13), which reduce the bending of the transition region 243 in response to forces imposed on the venous tip section 226 during disposition in the cardiovascular system of a patient. Between the reinforcing ridges 254, 256, the surface of the transition region 243 forms a longitudinally extending recess 258 having a floor 260 (FIG. 14) that rises smoothly and continuously from the planar surface 232 of the proximal portion 242 to the curved outer wall of the cylindrical distal portion 244.


In the vicinity of the curved outer wall of the cylindrical distal portion 244, the floor 260 of the recess 258 is penetrated by a guidewire aperture 262 that communicates between the exterior of the venous tip section 226 and the venous lumen 222 (FIG. 14). The planar surface 232 of venous tip section 226 is extended to a longitudinal point where the floor 260 of the transition region 243 merges with the wall of the cylindrical distal portion 244 so that an overhead view (FIG. 13) does not reveal the guidewire aperture 262. This forms a ledge of sorts that, in combination with parallel reinforcing ridges 254, 256, directs the guidewire 264 and maintains it in position as the split-tip catheter 200 is slid therealong into the cardiovascular system of the patient. To prepare for use, the insertion guidewire 264 is threaded into the split-tip catheter 200 by first passing the proximal end thereof into end opening 248 of the venous tip section 226 and along the venous lumen 222 within the distal portion 244, through the guidewire aperture 262 and into the end opening 234 of the arterial tip section 224 where it is advanced along the full length of arterial lumen 220 to exit the catheter tube 214 at a proximal end thereof.


While the split-tip catheters 100 and 200 are configured to allow for sheathless delivery into a cardiovascular system of a patient due to the presence of guidewire apertures 162 and 262, respectively, an improvement to related to the sheathed delivery of split-tip catheters is illustrated in FIGS. 15-20. With respect to FIGS. 15A-15B, a prior art split-tip catheter 310 is shown within a delivery sheath 370 to illustrate a potential problem solved by the present invention. Tip sections 340 and 350 are shown distal to dividing point 330. Each tip section 340 and 350 transitions at a distal end from a D-shaped lumen to a lumen that is circular in cross-section and each has a terminal end that is cut perpendicular to a longitudinal axis thereof. As shown in FIG. 15A, edges 348 and 358 located at the terminal ends of tip sections 340 and 350 abut the inside surface 372 of the sheath 370. Thus, as shown in FIG. 15B, when the catheter 310 is moved out of delivery sheath 370 and into a blood vessel in a direction 390, the opposing friction force 392 forces the tip sections in an outward direction into the sheath 370 as indicated by arrows 394 and 396. This movement of the tip sections 340 and 350 into the inside surface 372 of the delivery sheath 370 causes the edges 348 and 358 to catch or “snag” on the inside surface 372, resulting in difficult insertions or other attendant problems with the delivery process.


One potential method for alleviating this problem would be to use a larger diameter sheath so that the tip sections will have a greater distance to travel to come in contact with the inside surface of the sheath when the friction forces act on the tip sections, thereby minimizing the chance of a snag. However, this solution is flawed in that snags are still possible and the risk of air embolism is amplified due to the increase in surface area between the catheter and the sheath. FIG. 16 illustrates one embodiment of the present invention that addresses a solution to the sheathed delivery problems described. In particular, a multi-lumen catheter 410 having tip sections 440 and 450 distal to a dividing point 430 is shown, the catheter 410 being positioned within delivery sheath 370 having an inside surface 372. To prevent the terminal ends of the tip sections from catching or “snagging” on the inside surface 372 of the delivery sheath 370, a friction reducing structure is provided.


In FIG. 16, the friction reducing structure is illustrated as a slight protrusion or “bump” of material 480, which is positioned on the outside surface of tip sections 440 and 450 near the terminal ends thereof. Thus, as friction forces tend to push the tip sections outward from a central axis of the catheter 410 upon removal from the sheath 370 and into the blood vessel (as described above), the protrusion 480 provides a buffer to prevent edges 448 and 458 from coming into direct contact with the inside surface 372 of the delivery sheath 370 and also provides a relatively small surface area for contact. Of course, there are many ways for reducing friction utilizing the protrusions as discussed above, including using a plurality of protrusions on the catheter tip sections in various locations along their length. However, the embodiment shown in FIG. 16 is advantageous due to the small surface area utilized, the ease of manufacture and the wide-ranging applicability for use with a variety of catheter configurations.



FIG. 17 illustrates an alternate embodiment for reducing friction, wherein each of the tip sections 440 and 450 have a ring of material 482 around an end thereof distal to the dividing point 430. The rings 482, similar to the protrusions 480, distance the sharp edges of the tip sections 440 and 450 from the inside surface of a delivery sheath and therefore reduce friction forces associated with the delivery of a split-tip catheter from a delivery sheath and into a patient's vessel. The rings 480 may also act as a buffer of sorts for the tip sections 440 and 450 while within a patient's vessel by acting to keep the distal ends from coming into direct contact with the walls of the vessel.


Another embodiment for reducing friction comprises an inflatable material being positioned on one or more points along the catheter. In this embodiment, a small inflation lumen is positioned on the inner or outer of either or both arterial or venous lumens, extending from the proximal end of the catheter to the point on the catheter containing the inflatable material. When the catheter is positioned for delivery within a delivery sheath, air, gas or liquid is transmitted through the inflation lumen to the inflatable material, expanding said material into contact with the inner of the delivery sheath. Preferably, the inflatable material would be positioned close to the distal end of the catheter on the tip sections so that the goal of preventing the edges of the tip sections from coming into contact with the inside surface of the delivery sheath can be realized. Alternatively or in addition to the goal of reducing friction, placement of inflatable material on various areas on a surface of the catheter could act to remove clots and/or fibrin through the inflation thereof (i.e., by knocking the formations off of the surface upon inflation). Referring now to FIG. 18, the catheter 410 has balloons 444 and 454 positioned near the distal ends of the tip sections 440 and 450, respectively, and are connected to respective inflation lumens 442 and 452. Balloon 444 is shown in its inflated, expanded position for ready contact with the inside surface of a delivery sheath such as delivery sheath 370. Balloon 454 is shown in its deflated, unexpanded position.


In yet another embodiment of the present invention, a friction reducing structure is provided by positioning a ridge or ridges 380 on the inside surface 372 of delivery sheath 370, as shown in FIGS. 19 and 20. As with the embodiments involving protrusions positioned on the surface of the catheter, the ridge(s) 380 prevent direct contact of any sharp edges of a tip section with the inside surface 372 of the delivery sheath 370. The ridges 380 can be formed from a mound or bump of material or could also be formed from balloons as described with reference to FIG. 18.


It is noted that although the delivery problems presented with reference to FIGS. 15A and 15B are certainly more likely to be presented in terminal ends such as those shown, other tip configurations could also present problems with snags or tears, which problems can be minimized through any of the friction reducing structures described above.


Referring now to FIGS. 21A-21H, an improvement to prior art split-tip catheters that are releasably joined or “splittable” distal to the dividing point is illustrated, wherein increasing separation force is required to separate the tip sections from one another. An increasing separation force as used herein means that the bond strength between the tip sections of the catheter will be greater as measured from a distal end toward the dividing point. However, the releasably joined or splittable region need not extend over the entire length of the tip sections and need not begin adjacent the dividing point. Thus, while the releasably joined or splittable region could extend the entire distance from a terminal end of one or more tip sections to the dividing point, it could also span a much shorter distance along the tip sections such that the releasably joined or splittable region is not adjacent either the dividing point or a terminal end of one or more tip sections.


The creation of an increasing separation force between tip sections can be accomplished in a variety of ways, as one of skill in the art should appreciate, some of which ways will be described in detail below (though certainly many others would be within the scope of the present invention). In addition, although the examples herein are described with respect to an increasing separation force, the production of a decreasing separation force is also contemplated, the implementation of which should be apparent to one of skill in the art in light of the discussion regarding an increasing separation force. Further, the discussion with respect to the separation of splittable tip sections herein encompasses both permanent and temporary (i.e., releasably joined) separation.


The concept of increasing the required separation force to separate tip sections from one another is illustrated by way of example, not limitation, through the graphs in FIGS. 21A and 21B. In each of these graphs, the y-axis represents the separation force F required to separate the tip sections from one another and the x-axis represents the position P along the joined portion of the tip sections as measured beginning at a distal end thereof and moving toward the dividing point. The points on the graph, P1, P2 and P3 are points along the joined portion of the tip sections (as further illustrated in FIGS. 21C-21H), having corresponding increasing separation forces F1, F2 and F3. While three distinct points are shown, certainly any number of points are possible and are contemplated herein. The point PF corresponds to FE, which is the excessive separation force as defined above.


The graphs in FIGS. 21A and 21B illustrate two possibilities for varying the separation force along the length of a split-tip catheter, wherein said force is increasing as a function of position of joined portion of the tip sections when measured beginning at the a distal end thereof and moving in a proximal direction toward the dividing point. FIG. 21A illustrates a straight line continuous separation force, while FIG. 21B illustrates an incremental separation force accomplished in discreet steps, meaning that the change in force custom characterF is too great for spontaneous splitting.


One embodiment of tip sections having an increasing separation force is illustrated in FIG. 21C, where fusion points are shown on an inner surface 512 of a tip section 510 of a catheter 500 along a predetermined length L1 (tip section 510 is shown as separated from an adjacent tip section 520 for purposes of illustration). As used herein, the term “fusion point” refers to a fused surface area between a splittable interface and should not be restricted to a “point” per se. Thus, referring to FIG. 21C, the fusion points would be fused surface areas between the inner surface 512 of the tip section 510 and the inner surface 522 of the tip section 520 (even though the tip sections are shown as separate). In this embodiment, the fusion points will preferentially detach upon application of a consistent force relative to the surface area of the fusion.


As shown in FIG. 21C, the fusion points of a first zone 530, formed between P1 and P2, are lighter in shading than the fusion points of a second zone 540, formed between P2 and P3, which in turn are lighter in shading than the fusion points of a third zone 550, formed between P3 and PF. While the shading is shown to be uniform within each zone, one contemplated variation would be to increase the shading (i.e., fusion strength) within each zone when moving toward a higher number (i.e., P1 to P2) as shown in FIG. 21E. In effect, such a configuration creates subzones or additional fusion zones. The darker shaded fusion point in these embodiments represents a fusion point having a greater bond strength, meaning that the fusion points of the third zone 550 would have a greater bond strength than those of the second zone 540, which in turn would have a greater bond strength than those of a first zone 530. This effect could be accomplished, for example, by utilizing different adhesives or solvents for different zones, using various dilutions of adhesives or solvents for different zones, utilizing varying application times of the adhesive or solvent for different zones or using variable pressure upon bonding (more force on one end than another) for different zones, as will be described in greater depth below.


In addition to greater bond strength for the fusion points in adjacent zones in FIG. 21C, the number (density) of the fusion points are increased in each successive zone and within each fusion zone, with the third zone 550 having a greater number of fusion points than the second zone 540, in turn having a greater number of fusion points than the first zone 530. With a greater number of fusion points comes an increased surface area for fusion between inner surface 512 of the tip section 510 and inner surface 522 of the tip section 520, thereby increasing the required separation force when moving from the distal end of the catheter 500 to the proximal end of the catheter 500. Also, with the number of fusion points progressively increasing within each fusion zone, a continuous configuration is created. The combination of greater bond strength in fusion points between adjacent fusion zones and increasing number of fusion points within each fusion zone creates a hybrid continuous/stepped configuration, wherein the separation force increases within each zone following a continuous curve (as represented in FIG. 21A) and increases in a stepped manner with respect to adjacent zones (as represented in FIG. 21B).



FIG. 21D illustrates an embodiment of the present invention following the stepped configuration represented by FIG. 21B, wherein the number of fusion points within each fusion zone is uniform as is the bond strength of the fusion points within each fusion zone, but the bond strength of the fusion points is greater in each successive fusion zone as in FIG. 21C. FIG. 21E follows the continuous configuration represented by FIG. 21A, wherein the number of fusion points is uniform within each fusion zone, but the bond strength of the fusion zones is progressively increased as between fusion zones and within each fusion zone (i.e., the bond strength of the fusion points in the first fusion zone 530 are progressively increased as are those in the second fusion zone 540 and the third fusion zone 550). FIG. 21F follows a stepped configuration as the bond strength of the fusion points is the same in all fusion zones, but the number of fusion points is increased in each successive fusion zone (the number of fusion points is uniform within each zone). In FIG. 21G, the bond strength of the fusion points is the same in all fusion zones, as is the number of fusion points, but the size of the fusion points is increased in successive fusion points, creating a stepped configuration.


Yet another embodiment of the present invention with respect to the establishment of an increasing separation force is illustrated in FIG. 21H, where the zones themselves increase in size. A catheter 600 is shown with tip sections 610 and 620, having four discrete and separate fusion zones, indicated by shading (the shading representing fusion points), on inner surface 612. A first zone 630 is smaller and therefore has less surface area for adhesion than a second zone 640, which in turn is smaller than a third zone 650, which in turn is smaller than a fourth zone 660. In this embodiment, there are free zones that do not have fusion points thereon, positioned in between each of the four stated zones. The first, second, third and fourth zones 630-660 can consist of fusion points as described above, in any combination thereof. Thus, for example, the first zone 630 could have a certain density of fusion points, while the second zone 640 could have a somewhat higher separation force created by a larger size of fusion points.


A further embodiment of a catheter having a variable separation force is illustrated in FIG. 21I. In this figure, a catheter 700 is shown with tip sections 710 and 720, having a continuous fusion zone 730 that increases in size along L1 from a distal end to a dividing point. Of course, one of skill in the art will appreciate the myriad of possibilities within the scope of the present invention with respect to the varying of fusion points and establishment of an increasing separation force in light of the embodiments illustrated herein.


Methods for producing the desired effects with respect to the establishment of an increasing separation force, as described above, include (but are not limited to) utilizing constant separation stress with a variable area and using a variable separation stress with a constant area. Realization of these embodiments can be accomplished through many different bonding techniques, a few of which are described below.


With respect to constant separation stress over a variable area, a first potential technique is the use of adhesive bonding in creating a varying pattern of adhesive to join the tip sections of a split-tip catheter. Types of adhesive which could be used include epoxy and cyanoacrylates, although certainly other comparable adhesives would also be suitable. This idea has been explored above, for example, with respect to varying the density of the fusion points and the size of the fusion points. A second technique is the use of solvent bonding in creating a varying pattern of solvent to join the tip sections of a split-tip catheter. Examples of the types of solvents that could be employed include Tecoflex® 1-MP (Thermedics), methyl ethyl ketone (MEK), cyclohexanon and alcohol, though certainly others could be used. A third technique is the use of thermal welding, in which heat can be used to join the tip sections of a split-tip catheter. A fourth technique is the use of RF energy to fuse the tip sections of a split-tip catheter. Finally, a fifth technique is the use of variable extrusion where surface area of a joining web could be increased between two lumens during the extrusion process.


In reference to variable separation stress over a constant area, the techniques above would be applicable in a different way. Specifically, in an adhesive bonding technique, the concentration of the adhesive could be varied to produce the variable bond strength. This idea has been explored above with respect to varying the type of adhesive used. In a solvent bonding technique, the solvent could be varied or the pressure utilized to join the tip sections could be varied. In a thermal welding technique, the temperature or dwell time could be varied. In an RF fusion technique, variable RF energy could be utilized. Finally, in a variable extrusion technique, pressure, temperature or dwell time could be varied during the extrusion process.


Still another embodiment of the present invention with respect to the establishment of an increasing separation force is illustrated in FIGS. 22A and 22B, where the separation force is created by twisting the catheter upon formation thereof. FIG. 22A illustrates a gradual twist being applied to the catheter, while FIG. 22B illustrates a more abrupt twist over a shorter length. The twisting configuration imparts a variable separation force along the length of the catheter, increasing as measured from the distal end to the proximal end. For example, if a constant separation force is applied linearly to tip sections in a catheter having a 90° twisted septum, the force F a distance L away (i.e., the distal end of the catheter) would diminish to zero in the direction needed to continue the splitting, because F would be resolved in the tensile direction of the septum if the tube could not rotate. On the other hand, were the tube able to rotate, the force would not diminish to zero but would be reduced by the energy required to rotate the tube 90°.


The twisting action can be implemented in a number of ways, including employing a mandrel having a desired twist, which when inserted into a still warm tube, imparts the twist to the tube during cooling and utilizing a series of mandrels to force a previously straight tube into a desired twisted pattern, wherein heat is applied to reset the tubing configuration. Another technique would be to employ an extrusion die having a preset desired twist so that the twist is imparted to the catheter during formation thereof. Referring back to FIGS. 22A and 22B, the gradual twist 820 of the catheter 810 permits slow increase in resistance by transferring the splitting energy into rotational force if the catheter 810 is sufficiently flexible to twist when split. Differently, the abrupt twist 920 imparted to catheter 910 creates a tactile “positive stop,” which notifies a user when a predetermined position along the length of the catheter 910 has been attained. Multiple twists could also be employed to provide a tactile measurement method for the user, and to provide an incremental separation force as described above in FIG. 21B.


Although improvements to the functioning and usability of a split-tip catheter have been presented separately herein, the improvements described above (for example, openings positioned near a dividing point of a split tip catheter, positioning of a guidewire aperture in a venous tip section, configuration of arterial and venous tip sections with respect to one another, friction reducing structures provided on a delivery sheath and/or a catheter, varying the separation force required to separate tip sections from one another, etc.) should not be considered exclusive and instead should be considered for use in conjunction with one another.


The present invention has been described above in terms of certain preferred embodiments so that an understanding of the present invention can be conveyed. However, there are many alternative arrangements for a multi-lumen catheter not specifically described herein but with which the present invention is applicable. Although specific features have been provided, the multi-lumen catheter of the present invention would equally be embodied by other configurations not specifically recited herein. The scope of the present invention should therefore not be limited by the embodiments illustrated, but rather it should be understood that the present invention has wide applicability with respect to catheter systems generally. All modifications, variations, or equivalent elements and implementations that are within the scope of the appended claims should therefore be considered within the scope of the invention.

Claims
  • 1. A multi-lumen catheter, comprising: a generally cylindrical body enclosing a first and second lumen separated by a generally planar septum;a first tip section extending from a distal end of the body, the first tip section comprising: a generally planar surface extending from the septum;a distal end surface oblique to the generally planar surface; andan opening in the distal end surface; anda second tip section comprising: a proximal segment having a proximal cross-sectional area and a generally planar surface extending from the distal end of the body;a transition segment extending from the proximal segment; anda distal segment extending from the transition segment, the distal segment having a distal cross-sectional area greater than the proximal cross-sectional area.
  • 2. The multi-lumen catheter according to claim 1, wherein the distal end surface of the first tip section includes rounded corners.
  • 3. The multi-lumen catheter according to claim 1, wherein a distal end of the second tip section includes a beveled surface forming an angle in a range of about 25 degrees and about 75 degrees with a longitudinal axis of the second tip section.
  • 4. The multi-lumen catheter according to claim 1, wherein the planar surface of the first tip section includes a first planar surface opening adjacent the distal end of the body.
  • 5. The multi-lumen catheter according to claim 4, wherein the planar surface of the first tip section includes one or more planar surface openings distal to the first planar surface opening.
  • 6. The multi-lumen catheter according to claim 1, wherein a medial portion of the body is curved.
PRIORITY

This application is a continuation of U.S. patent application Ser. No. 11/874,447, filed Oct. 18, 2007, now U.S. Pat. No. 8,808,227, which is a continuation of U.S. patent application Ser. No. 10/371,774, filed Feb. 21, 2003, now U.S. Pat. No. 7,393,339, each of which is incorporated by reference into this application as if fully set forth herein.

US Referenced Citations (659)
Number Name Date Kind
701075 McCully May 1902 A
1696018 Scheliberg Dec 1928 A
1856811 Inaki May 1932 A
2024982 Scott Dec 1935 A
2173527 Agayoff Sep 1939 A
2286462 Chaffin Jun 1942 A
2393002 Smith Jan 1946 A
2748769 Huber Jun 1956 A
2910981 Wilson et al. Nov 1959 A
3144868 Jascalevich Aug 1964 A
3176690 H'Doubler Apr 1965 A
3256885 Higgins et al. Jun 1966 A
3308822 De Luca Mar 1967 A
3416532 Grossman Dec 1968 A
3426759 Smith Feb 1969 A
3460255 Hutson Aug 1969 A
D217795 Spaven Jun 1970 S
3612038 Halligan Oct 1971 A
3736939 Taylor Jun 1973 A
3805794 Schlesinger Apr 1974 A
3812851 Rodriguez May 1974 A
3848604 Sackner Nov 1974 A
3890977 Wilson Jun 1975 A
3929126 Corsaut Dec 1975 A
3935857 Co Feb 1976 A
3995623 Blake et al. Dec 1976 A
4068659 Moorehead Jan 1978 A
4072146 Howes Feb 1978 A
4072153 Swartz Feb 1978 A
4098275 Consalvo Jul 1978 A
4114625 Onat Sep 1978 A
4117836 Erikson Oct 1978 A
4129129 Amrine Dec 1978 A
4134402 Mahurkar Jan 1979 A
4149535 Volder et al. Apr 1979 A
4180068 Jacobsen et al. Dec 1979 A
D254444 Levine Mar 1980 S
4248224 Jones Feb 1981 A
4276880 Malmin Jul 1981 A
4292976 Banka Oct 1981 A
4299228 Peters Nov 1981 A
4300550 Gandi et al. Nov 1981 A
4309994 Grunwald Jan 1982 A
4327722 Groshong et al. May 1982 A
4385631 Uthmann et al. May 1983 A
4392855 Oreopoulos et al. Jul 1983 A
4403983 Edelman et al. Sep 1983 A
4405313 Sisley et al. Sep 1983 A
4406656 Hattler et al. Sep 1983 A
D272651 Mahurkar Feb 1984 S
4431426 Groshong et al. Feb 1984 A
4432722 Bohan, Jr. et al. Feb 1984 A
4432752 Marlon Feb 1984 A
4445893 Bodicky May 1984 A
4451252 Martin et al. May 1984 A
4453928 Steiger Jun 1984 A
4465482 Tittel et al. Aug 1984 A
4490138 Lipsky et al. Dec 1984 A
4493696 Uldall et al. Jan 1985 A
RE31873 Howes Apr 1985 E
4531933 Norton et al. Jul 1985 A
4543087 Sommercorn et al. Sep 1985 A
4545373 Christoudias Oct 1985 A
4549879 Groshong et al. Oct 1985 A
4557261 Rugheimer et al. Dec 1985 A
4568329 Mahurkar Feb 1986 A
4568338 Todd Feb 1986 A
4573476 Ruiz Mar 1986 A
4581012 Brown et al. Apr 1986 A
4583968 Mahurkar Apr 1986 A
4583986 Lapidus Apr 1986 A
4601697 Mammolenti et al. Jul 1986 A
4619643 Bai Oct 1986 A
4623327 Mahurkar Nov 1986 A
4626240 Edelman et al. Dec 1986 A
4642101 Krolikowski et al. Feb 1987 A
4643711 Bates Feb 1987 A
4666426 Aigner et al. May 1987 A
4668221 Luther May 1987 A
4670009 Bullock Jun 1987 A
4675004 Hadford et al. Jun 1987 A
4681122 Winters et al. Jul 1987 A
4681564 Landreneau Jul 1987 A
4681570 Dalton Jul 1987 A
4682978 Martin et al. Jul 1987 A
4687471 Twardowski et al. Aug 1987 A
4692141 Mahurkar Sep 1987 A
4694838 Wijayarthna et al. Sep 1987 A
4701159 Brown et al. Oct 1987 A
4702917 Schindler Oct 1987 A
4713171 Polaschegg Dec 1987 A
4717379 Ekholmer et al. Jan 1988 A
4735620 Ruiz Apr 1988 A
4737141 Spits et al. Apr 1988 A
4737152 Alchas Apr 1988 A
4738667 Galloway Apr 1988 A
4748808 Hill Jun 1988 A
4755176 Patel Jul 1988 A
4769016 Labianca Sep 1988 A
4770652 Mahurkar Sep 1988 A
4772268 Bates Sep 1988 A
4772269 Twardowski et al. Sep 1988 A
4776841 Catalano Oct 1988 A
4777951 Cribier et al. Oct 1988 A
4784638 Ghajar et al. Nov 1988 A
4790809 Kuntz Dec 1988 A
4795439 Guest Jan 1989 A
4801297 Mueller Jan 1989 A
D300060 Molgaard-Nielsen Feb 1989 S
4804359 Grunwald et al. Feb 1989 A
4808155 Mahurkar Feb 1989 A
4808163 Laub Feb 1989 A
4809710 Williamson Mar 1989 A
4820265 DeSatnick et al. Apr 1989 A
4832687 Smith, III May 1989 A
4834709 Banning et al. May 1989 A
4842582 Mahurkar Jun 1989 A
4842592 Caggiani et al. Jun 1989 A
4846814 Ruiz Jul 1989 A
4863441 Lindsay et al. Sep 1989 A
4867742 Calderon Sep 1989 A
4892518 Cupp et al. Jan 1990 A
4894057 Howes Jan 1990 A
4895561 Mahurkar Jan 1990 A
4898591 Jang et al. Feb 1990 A
4906238 Greenfeld et al. Mar 1990 A
4925452 Melinyshyn et al. May 1990 A
4927418 Dake et al. May 1990 A
4935004 Cruz Jun 1990 A
4935010 Cox et al. Jun 1990 A
4935044 Schoenpflug et al. Jun 1990 A
4936826 Amarasinghe Jun 1990 A
4950232 Ruzicka et al. Aug 1990 A
4950259 Geary et al. Aug 1990 A
4951665 Schneider Aug 1990 A
4961729 Vaillancourt Oct 1990 A
4961731 Bodicky et al. Oct 1990 A
4961809 Martin et al. Oct 1990 A
4968307 Dake et al. Nov 1990 A
4969890 Sugita et al. Nov 1990 A
4981477 Schon et al. Jan 1991 A
4985014 Orejola Jan 1991 A
4990138 Bacich Feb 1991 A
4994027 Farrell Feb 1991 A
4995865 Gahara et al. Feb 1991 A
5009636 Wortley et al. Apr 1991 A
5015230 Martin et al. May 1991 A
5016640 Ruiz May 1991 A
5021044 Sharkawy Jun 1991 A
5041101 Seder et al. Aug 1991 A
5041107 Heil, Jr. Aug 1991 A
5049138 Chevalier et al. Sep 1991 A
5053003 Dadson et al. Oct 1991 A
5053004 Markel et al. Oct 1991 A
5053023 Martin Oct 1991 A
5057073 Martin Oct 1991 A
5059170 Cameron Oct 1991 A
5069673 Shwab Dec 1991 A
5074841 Ademovic et al. Dec 1991 A
5084013 Takase et al. Jan 1992 A
5098412 Shiu et al. Mar 1992 A
5100395 Rosenberg et al. Mar 1992 A
5102402 Dror et al. Apr 1992 A
5106368 Uldall et al. Apr 1992 A
5106376 Mononen et al. Apr 1992 A
5111829 Alvarez de Toledo May 1992 A
5112301 Fenton, Jr. et al. May 1992 A
5114423 Kasprzyk et al. May 1992 A
5117836 Millar Jun 1992 A
5120299 Lombardi Jun 1992 A
5120304 Sasaki Jun 1992 A
5122125 Deuss et al. Jun 1992 A
5125904 Lee Jun 1992 A
5129891 Young Jul 1992 A
5135599 Martin et al. Aug 1992 A
5139486 Moss Aug 1992 A
5156592 Martin et al. Oct 1992 A
5163928 Hobbs et al. Nov 1992 A
5167623 Cianci et al. Dec 1992 A
5171216 Dasse et al. Dec 1992 A
5171227 Twardowski et al. Dec 1992 A
5178616 Uemiya et al. Jan 1993 A
5188592 Hakki Feb 1993 A
5188593 Martin Feb 1993 A
5190520 Fenton, Jr. et al. Mar 1993 A
5190529 McCrory et al. Mar 1993 A
5191898 Millar Mar 1993 A
5195962 Martin et al. Mar 1993 A
5197951 Mahurkar Mar 1993 A
5197973 Pang et al. Mar 1993 A
5197976 Herweck et al. Mar 1993 A
5201723 Quinn Apr 1993 A
5207648 Gross May 1993 A
5207650 Martin May 1993 A
5209723 Twardowski et al. May 1993 A
5209725 Roth May 1993 A
5209742 Venema et al. May 1993 A
5215527 Beck et al. Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5221256 Mahurkar Jun 1993 A
5222949 Kaldany Jun 1993 A
5226880 Martin et al. Jul 1993 A
5234438 Semrad Aug 1993 A
5236016 Vogelsang et al. Aug 1993 A
5242398 Knoll et al. Sep 1993 A
5246430 MacFarlane Sep 1993 A
5250034 Appling et al. Oct 1993 A
5254084 Geary Oct 1993 A
5273527 Schatz et al. Dec 1993 A
5273534 Knoepfler Dec 1993 A
5279596 Castaneda et al. Jan 1994 A
5279599 Wilk Jan 1994 A
5306240 Berry Apr 1994 A
5312337 Flaherty et al. May 1994 A
5312357 Buijs et al. May 1994 A
5318517 Reiman Jun 1994 A
5322519 Ash Jun 1994 A
5324274 Martin Jun 1994 A
5330432 Yoon Jul 1994 A
5338308 Wilk Aug 1994 A
5342295 Imran Aug 1994 A
5342386 Trotta Aug 1994 A
5346471 Raulerson Sep 1994 A
5348536 Young et al. Sep 1994 A
5350358 Martin Sep 1994 A
5360397 Pinchuk Nov 1994 A
5360407 Leonard et al. Nov 1994 A
5364344 Beattie et al. Nov 1994 A
5374245 Mahurkar Dec 1994 A
5378230 Mahurkar Jan 1995 A
5380276 Miller et al. Jan 1995 A
5380290 Makower et al. Jan 1995 A
5382238 Abrahamson et al. Jan 1995 A
5389087 Miraki Feb 1995 A
5389090 Fischell et al. Feb 1995 A
5395316 Martin et al. Mar 1995 A
5399168 Wadsworth, Jr. et al. Mar 1995 A
5403291 Abrahamson Apr 1995 A
5405320 Twardowski et al. Apr 1995 A
5405341 Martin Apr 1995 A
5409463 Thomas et al. Apr 1995 A
5417668 Setzer et al. May 1995 A
5423768 Folden et al. Jun 1995 A
5431661 Koch Jul 1995 A
5451026 Smith Sep 1995 A
5451206 Young Sep 1995 A
5451233 Yock Sep 1995 A
5458570 May, Jr. Oct 1995 A
5458582 Nakao Oct 1995 A
5462533 Daugherty Oct 1995 A
5472417 Martin et al. Dec 1995 A
5472432 Martin Dec 1995 A
5476453 Mehta Dec 1995 A
5480380 Martin Jan 1996 A
5486159 Mahurkar Jan 1996 A
5489278 Abrahamson Feb 1996 A
5496292 Burnham Mar 1996 A
5496872 Constancis et al. Mar 1996 A
5505710 Dorsey, III Apr 1996 A
5507723 Keshaviah Apr 1996 A
5509897 Twardowski et al. Apr 1996 A
5509900 Kirkman Apr 1996 A
5509902 Raulerson Apr 1996 A
5542925 Orth Aug 1996 A
5545373 Maziasz et al. Aug 1996 A
5556390 Hicks Sep 1996 A
5556930 Brehm et al. Sep 1996 A
5558635 Cannon Sep 1996 A
5562609 Brumbach Oct 1996 A
5562696 Nobles et al. Oct 1996 A
5569182 Twardowski et al. Oct 1996 A
5569195 Saab Oct 1996 A
5571093 Cruz et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5599304 Shaari Feb 1997 A
5599328 Stevens Feb 1997 A
5607462 Imran Mar 1997 A
5624392 Saab Apr 1997 A
5624413 Markel et al. Apr 1997 A
5632729 Cai et al. May 1997 A
5637102 Tolkoff et al. Jun 1997 A
5642270 Green et al. Jun 1997 A
5655867 Gysi et al. Aug 1997 A
5662606 Cimino et al. Sep 1997 A
5665067 Linder et al. Sep 1997 A
5674237 Ott Oct 1997 A
5685867 Twardowski et al. Nov 1997 A
5686867 Sutardja et al. Nov 1997 A
5693030 Lee et al. Dec 1997 A
5695457 St. Goar et al. Dec 1997 A
5704915 Melsky et al. Jan 1998 A
5713849 Bosma et al. Feb 1998 A
5713853 Clark et al. Feb 1998 A
5717216 McCoy et al. Feb 1998 A
5718678 Fleming, III Feb 1998 A
5718692 Schon et al. Feb 1998 A
5720735 Dorros Feb 1998 A
5738649 Macoviak Apr 1998 A
5741329 Agrawal et al. Apr 1998 A
5743873 Cai et al. Apr 1998 A
5752939 Makoto May 1998 A
5769796 Palermo et al. Jun 1998 A
5772643 Howell et al. Jun 1998 A
5776096 Fields Jul 1998 A
5776111 Tesio Jul 1998 A
5785686 Runge Jul 1998 A
5792094 Stevens et al. Aug 1998 A
5792123 Ensminger Aug 1998 A
5797869 Martin et al. Aug 1998 A
5800384 Russell et al. Sep 1998 A
5800414 Cazal et al. Sep 1998 A
5800516 Fine et al. Sep 1998 A
5807311 Palestrant Sep 1998 A
5807318 St. Goar et al. Sep 1998 A
5807329 Gelman Sep 1998 A
5809897 Powell et al. Sep 1998 A
5810789 Powers et al. Sep 1998 A
5814016 Valley et al. Sep 1998 A
5830184 Basta Nov 1998 A
5830196 Hicks Nov 1998 A
5833671 Macoviak et al. Nov 1998 A
5843048 Gross Dec 1998 A
5858009 Jonkman Jan 1999 A
5861010 Boussignac et al. Jan 1999 A
5868717 Prosl Feb 1999 A
5873865 Horzewski et al. Feb 1999 A
5876366 Dykstra et al. Mar 1999 A
5876426 Kume et al. Mar 1999 A
5882347 Mouris-Laan et al. Mar 1999 A
5891111 Ismael et al. Apr 1999 A
5904670 Schreiner May 1999 A
5911715 Berg et al. Jun 1999 A
5913848 Luther et al. Jun 1999 A
5916208 Luther et al. Jun 1999 A
5919160 Sanfilippo, II Jul 1999 A
5944732 Raulerson et al. Aug 1999 A
5947937 Urrutia et al. Sep 1999 A
5947953 Ash et al. Sep 1999 A
5957879 Roberts et al. Sep 1999 A
5957893 Luther et al. Sep 1999 A
5957912 Heitzmann Sep 1999 A
5961486 Twardowski et al. Oct 1999 A
5964796 Imran Oct 1999 A
5976103 Martin Nov 1999 A
5976120 Chow et al. Nov 1999 A
5980551 Summers et al. Nov 1999 A
5984908 Davis et al. Nov 1999 A
5989206 Prosl et al. Nov 1999 A
5989213 Maginot Nov 1999 A
6001079 Pourchez Dec 1999 A
6033382 Basta Mar 2000 A
6036654 Quinn et al. Mar 2000 A
6059771 Balbierz et al. May 2000 A
6074374 Fulton Jun 2000 A
6086555 Eliasen et al. Jul 2000 A
6090096 St. Goar et al. Jul 2000 A
6099513 Spehalski Aug 2000 A
6103778 Hyon et al. Aug 2000 A
6106540 White et al. Aug 2000 A
6113572 Gailey et al. Sep 2000 A
6117117 Mauch Sep 2000 A
6120494 Jonkman Sep 2000 A
6126631 Loggie Oct 2000 A
6143013 Samson Nov 2000 A
6146354 Beil Nov 2000 A
6146373 Cragg et al. Nov 2000 A
6152909 Bagaoisan et al. Nov 2000 A
6156016 Maginot Dec 2000 A
6161547 Barbut Dec 2000 A
6178356 Chastain et al. Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6190349 Ash Feb 2001 B1
6190371 Maginot et al. Feb 2001 B1
6193685 Goodin Feb 2001 B1
6196996 Teirstein Mar 2001 B1
6206849 Martin et al. Mar 2001 B1
6210365 Afzal Apr 2001 B1
6210380 Mauch Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6224622 Kotzev May 2001 B1
6238406 Ellis et al. May 2001 B1
6264627 Liska et al. Jul 2001 B1
6273879 Keith et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6280423 Davey et al. Aug 2001 B1
6287326 Pecor Sep 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6293958 Berry et al. Sep 2001 B1
6296631 Chow Oct 2001 B2
6299631 Shalaby Oct 2001 B1
6322551 Brugger Nov 2001 B1
6328730 Harkrider, Jr. Dec 2001 B1
6342120 Basta Jan 2002 B1
6361529 Goodin et al. Mar 2002 B1
6383172 Barbut May 2002 B1
6394141 Wages et al. May 2002 B2
6394142 Woelfel et al. May 2002 B1
6409700 Siegel, Jr. et al. Jun 2002 B1
6413228 Hung et al. Jul 2002 B1
6428513 Abrahamson Aug 2002 B1
6443922 Roberts et al. Sep 2002 B1
6450988 Bradshaw Sep 2002 B1
6453185 O'Keefe Sep 2002 B1
6454997 Divino, Jr. et al. Sep 2002 B1
6463335 Munch et al. Oct 2002 B1
6468287 Baugh Oct 2002 B1
6475207 Maginot et al. Nov 2002 B1
6475209 Larson et al. Nov 2002 B1
6478789 Spehalski et al. Nov 2002 B1
6482169 Kuhle Nov 2002 B1
6533763 Schneiter Mar 2003 B1
6565594 Herweck et al. May 2003 B1
6576001 Werneth et al. Jun 2003 B2
6582459 Lau et al. Jun 2003 B1
6585705 Maginot et al. Jul 2003 B1
6592565 Twardowski Jul 2003 B2
6595966 Davey et al. Jul 2003 B2
6620118 Prosl et al. Sep 2003 B1
6638242 Wilson et al. Oct 2003 B2
6659134 Navis Dec 2003 B2
6682498 Ross Jan 2004 B2
6682519 Schon Jan 2004 B1
6691625 Duncan Feb 2004 B2
6695832 Schon et al. Feb 2004 B2
6702776 Quinn Mar 2004 B2
6712797 Southern, Jr. Mar 2004 B1
6712798 Constantz Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6719749 Schweikert et al. Apr 2004 B1
6723084 Maginot et al. Apr 2004 B1
6723114 Shalaby Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6752827 Ross et al. Jun 2004 B2
6755851 Noda et al. Jun 2004 B2
6758836 Zawacki Jul 2004 B2
6786664 Claramunt et al. Sep 2004 B2
6786884 DeCant, Jr. et al. Sep 2004 B1
6796991 Nardeo Sep 2004 B2
6797107 Kotzey Sep 2004 B1
6808510 DiFiore Oct 2004 B1
6814718 McGuckin, Jr. et al. Nov 2004 B2
6819951 Patel et al. Nov 2004 B2
6821287 Jang Nov 2004 B1
6824554 Jang Nov 2004 B1
6835452 Hamerski Dec 2004 B1
6837864 Bertolero et al. Jan 2005 B1
6852079 Miyano Feb 2005 B2
6852097 Fulton, III Feb 2005 B1
6858019 McGuckin, Jr. et al. Feb 2005 B2
6872198 Wilson et al. Mar 2005 B1
6878143 Andersen Apr 2005 B2
6881211 Schweikert et al. Apr 2005 B2
6884253 McFarlane Apr 2005 B1
6911014 Wentling et al. Jun 2005 B2
6913601 St. Goar et al. Jul 2005 B2
6916313 Cunningham Jul 2005 B2
6921396 Wilson et al. Jul 2005 B1
6921411 Yock Jul 2005 B2
6934142 Grosse et al. Aug 2005 B2
6966886 Appling Nov 2005 B2
6969381 Voorhees Nov 2005 B2
6979318 McDonald et al. Dec 2005 B1
6991625 Gately et al. Jan 2006 B1
D515211 Chesnin Feb 2006 S
6997894 Caresio Feb 2006 B2
7008395 Loggie Mar 2006 B1
7011645 McGuckin, Jr. et al. Mar 2006 B2
7018384 Skakoon Mar 2006 B2
7029467 Currier et al. Apr 2006 B2
7066914 Andersen Jun 2006 B2
7066925 Gately et al. Jun 2006 B2
7074213 McGuckin, Jr. et al. Jul 2006 B2
7077829 McGuckin, Jr. et al. Jul 2006 B2
7087053 Vanney Aug 2006 B2
7090654 Lotito et al. Aug 2006 B2
7108674 Quinn Sep 2006 B2
D530420 Chesnin Oct 2006 S
7128734 Wilson et al. Oct 2006 B1
7130700 Gardeski et al. Oct 2006 B2
7141035 Haggstrom Nov 2006 B2
RE39451 Kuhle Dec 2006 E
7182746 Haarala et al. Feb 2007 B2
7300430 Wilson et al. Nov 2007 B2
7322953 Redinger Jan 2008 B2
7347852 Hobbs et al. Mar 2008 B2
7381204 Wilson et al. Jun 2008 B2
7393339 Zawacki et al. Jul 2008 B2
7422571 Schweikert et al. Sep 2008 B2
7465286 Patterson et al. Dec 2008 B2
7485107 DiFiore et al. Feb 2009 B2
7569029 Clark Aug 2009 B2
7575563 Appling Aug 2009 B2
7651482 Harris Jan 2010 B2
7686823 Pingleton et al. Mar 2010 B2
7798999 Bailey et al. Sep 2010 B2
7972465 Patterson et al. Jul 2011 B2
8021321 Zawacki Sep 2011 B2
8066660 Gregersen et al. Nov 2011 B2
8092415 Moehle Jan 2012 B2
8100863 Moehle et al. Jan 2012 B2
8152951 Zawacki et al. Apr 2012 B2
8206371 Nimkar et al. Jun 2012 B2
8292841 Gregersen Oct 2012 B2
8500939 Nimkar et al. Aug 2013 B2
8540661 Gregersen Sep 2013 B2
8597275 Nimkar et al. Dec 2013 B2
8696614 Gregersen et al. Apr 2014 B2
8808227 Zawacki et al. Aug 2014 B2
8894601 Moehle et al. Nov 2014 B2
8992454 Anand Mar 2015 B2
20010041857 Sansoucy Nov 2001 A1
20010041873 Dopper et al. Nov 2001 A1
20020013569 Sterman et al. Jan 2002 A1
20020026156 Quinn Feb 2002 A1
20020086047 Mueller et al. Jul 2002 A1
20020087108 Maginot et al. Jul 2002 A1
20020087145 Ehwald et al. Jul 2002 A1
20020091362 Maginot et al. Jul 2002 A1
20020091430 Dobak et al. Jul 2002 A1
20020099326 Wilson Jul 2002 A1
20020099327 Wilson et al. Jul 2002 A1
20020107506 McGuckin et al. Aug 2002 A1
20020138031 Ross Sep 2002 A1
20020169490 Noda et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20030023198 Twardowski Jan 2003 A1
20030088213 Schweikert et al. May 2003 A1
20030093027 McGuckin et al. May 2003 A1
20030097091 Hobbs et al. May 2003 A1
20030144623 Heath et al. Jul 2003 A1
20030149395 Zawacki Aug 2003 A1
20030153898 Schon et al. Aug 2003 A1
20030187411 Constantz Oct 2003 A1
20030204179 Davey et al. Oct 2003 A1
20040039350 McKittrick Feb 2004 A1
20040054321 Schon et al. Mar 2004 A1
20040059314 Schon et al. Mar 2004 A1
20040064086 Gottlieb et al. Apr 2004 A1
20040065333 Wilson et al. Apr 2004 A1
20040075198 Schweikert et al. Apr 2004 A1
20040087892 Cunningham May 2004 A1
20040092863 Raulerson et al. May 2004 A1
20040097863 Appling May 2004 A1
20040097903 Raulerson May 2004 A1
20040122418 Voorhees Jun 2004 A1
20040147903 Latini Jul 2004 A1
20040167463 Zawacki et al. Aug 2004 A1
20040171997 Wilson et al. Sep 2004 A1
20040172003 Wilson et al. Sep 2004 A1
20040176739 Stephens et al. Sep 2004 A1
20040193102 Haggstrom Sep 2004 A1
20040210180 Altman Oct 2004 A1
20040210187 Zawacki Oct 2004 A1
20040210237 Ross et al. Oct 2004 A1
20040220550 Schryver Nov 2004 A1
20040230204 Wortley et al. Nov 2004 A1
20040243095 Nimkar et al. Dec 2004 A1
20040249337 DiFiore Dec 2004 A1
20050003322 Logan et al. Jan 2005 A1
20050004504 Frye et al. Jan 2005 A1
20050013341 Baghai Jan 2005 A1
20050025641 Shibata et al. Feb 2005 A1
20050027282 Schweikert et al. Feb 2005 A1
20050027289 Castellano et al. Feb 2005 A1
20050033222 Haggstrom et al. Feb 2005 A1
20050033264 Redinger Feb 2005 A1
20050054989 McGuckin et al. Mar 2005 A1
20050055012 Trerotola Mar 2005 A1
20050059925 Maginot et al. Mar 2005 A1
20050070842 Lotito et al. Mar 2005 A1
20050080398 Markel et al. Apr 2005 A1
20050085765 Voorhees Apr 2005 A1
20050096585 Schon et al. May 2005 A1
20050113904 Shank et al. May 2005 A1
20050131341 McGuckin et al. Jun 2005 A1
20050171469 Cunningham Aug 2005 A1
20050187535 Wilson et al. Aug 2005 A1
20050215977 Uschold Sep 2005 A1
20050228339 Clark Oct 2005 A1
20050245900 Ash Nov 2005 A1
20050251190 McFarlane Nov 2005 A1
20050256461 DiFiore et al. Nov 2005 A1
20050261663 Patterson et al. Nov 2005 A1
20050267400 Haarala et al. Dec 2005 A1
20050277862 Anand Dec 2005 A1
20050283111 Maurice Dec 2005 A1
20050288623 Hjalmarsson Dec 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060004316 Difiore et al. Jan 2006 A1
20060004325 Hamatake et al. Jan 2006 A1
20060009783 Rome et al. Jan 2006 A1
20060015072 Raulerson Jan 2006 A1
20060015130 Voorhees et al. Jan 2006 A1
20060030827 Raulerson et al. Feb 2006 A1
20060047267 Gately et al. Mar 2006 A1
20060047268 Stephens Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060064072 Gately et al. Mar 2006 A1
20060095062 Stephens May 2006 A1
20060100572 DiMatteo et al. May 2006 A1
20060161100 Hamboly Jul 2006 A1
20060184142 Schon et al. Aug 2006 A1
20060189922 Amarasinghe et al. Aug 2006 A1
20060200111 Moehle et al. Sep 2006 A1
20060206094 Chesnin et al. Sep 2006 A1
20060251612 Kotzev et al. Nov 2006 A1
20060253063 Schweikert Nov 2006 A1
20060271012 Canaud et al. Nov 2006 A1
20070005003 Patterson et al. Jan 2007 A1
20070019181 Sinclair et al. Jan 2007 A1
20070066964 Atkins Mar 2007 A1
20070078478 Atkins et al. Apr 2007 A1
20070106206 Appling May 2007 A1
20070129704 O'Mahony et al. Jun 2007 A1
20070167925 Jacqmein Jul 2007 A1
20070191810 Kennedy Aug 2007 A1
20070225661 Ash et al. Sep 2007 A1
20070225682 Ash et al. Sep 2007 A1
20070282274 Chesnin Dec 2007 A1
20080021417 Zawacki et al. Jan 2008 A1
20080039774 Zawacki et al. Feb 2008 A1
20080065029 Racz Mar 2008 A1
20080082079 Braga et al. Apr 2008 A1
20080082080 Braga Apr 2008 A1
20080097409 Stephens Apr 2008 A1
20080172012 Hiniduma-Lokuge et al. Jul 2008 A1
20080214980 Anand Sep 2008 A1
20080214992 Haarala et al. Sep 2008 A1
20090112153 Gregersen et al. Apr 2009 A1
20090118661 Moehle et al. May 2009 A1
20090118701 Nimkar et al. May 2009 A1
20090118707 Schweikert et al. May 2009 A1
20090118755 Maliglowka et al. May 2009 A1
20090138034 Maliglowka et al. May 2009 A1
20090157051 Appling et al. Jun 2009 A1
20090187141 Lareau et al. Jul 2009 A1
20090192435 Gregersen Jul 2009 A1
20090204052 Nimkar et al. Aug 2009 A1
20090204079 Nimkar et al. Aug 2009 A1
20090204083 O'Donnell et al. Aug 2009 A1
20090205189 Nimkar et al. Aug 2009 A1
20090209940 Nimkar et al. Aug 2009 A1
20090292248 Schon et al. Nov 2009 A1
20100081986 Matson et al. Apr 2010 A1
20100331780 Bellisario et al. Dec 2010 A1
20110020418 Bosley, Jr. et al. Jan 2011 A1
20120059304 Gregersen et al. Mar 2012 A1
20120089070 Moehle et al. Apr 2012 A1
20130018405 Onishi et al. Jan 2013 A1
20130079752 Gregersen Mar 2013 A1
20130253445 Nimkar et al. Sep 2013 A1
20140025042 Gregersen Jan 2014 A1
20140088510 Nimkar et al. Mar 2014 A1
20140228742 Gregersen et al. Aug 2014 A1
20140276472 VanderStek et al. Sep 2014 A1
20140277052 Haselby et al. Sep 2014 A1
20140336687 Iwase et al. Nov 2014 A1
20150073336 Moehle et al. Mar 2015 A1
20150088100 Oborn et al. Mar 2015 A1
Foreign Referenced Citations (57)
Number Date Country
834211 Feb 1976 BE
1150122 Jul 1983 CA
2474351 Aug 2003 CA
2788836 Jun 2006 CN
101918067 Dec 2010 CN
201310073124 Mar 2013 CN
103170050 Jun 2013 CN
101918066 Jul 2013 CN
8815869 Feb 1989 DE
9108132 Sep 1991 DE
102005051211 May 2007 DE
0030854 Jun 1981 EP
0132344 Jan 1985 EP
0301854 Feb 1989 EP
0332366 Sep 1989 EP
0386408 Sep 1990 EP
0453234 Oct 1991 EP
0476796 Mar 1992 EP
0495263 Jul 1992 EP
0650740 May 1995 EP
0711574 May 1996 EP
1471966 Nov 2004 EP
1599247 Nov 2005 EP
1503469 Mar 1978 GB
56-136569 Oct 1981 JP
8-510935 Nov 1996 JP
2001137350 May 2001 JP
2008500081 Jan 2008 JP
4827377 Nov 2011 JP
459237 Feb 1975 SU
9108132 Jun 1991 WO
9316741 Sep 1993 WO
9316752 Sep 1993 WO
9709086 Mar 1997 WO
9717102 May 1997 WO
9722374 Jun 1997 WO
9737699 Oct 1997 WO
9904844 Feb 1999 WO
0023137 Apr 2000 WO
02058776 Aug 2002 WO
02083223 Oct 2002 WO
03030960 Apr 2003 WO
03033049 Apr 2003 WO
03066148 Aug 2003 WO
04075962 Sep 2004 WO
04096334 Nov 2004 WO
04112876 Dec 2004 WO
2005018712 Mar 2005 WO
2005023336 Mar 2005 WO
2005077449 Aug 2005 WO
2005084741 Sep 2005 WO
2005118039 Dec 2005 WO
2006034877 Apr 2006 WO
2009051967 Apr 2009 WO
2009055332 Apr 2009 WO
2009059220 May 2009 WO
2015077560 May 2015 WO
Non-Patent Literature Citations (224)
Entry
Haire, et al, Thrombotic Complications of Subclavian Apheresis catheters in Cancer Patients: Prevention With Heparin Infusion, Journal of Clinical Apheresis, 1990, vol. 5, pp. 188-191.
Hull, et al., The Groshong Catheter: Initial Experience and Early Results of Imaging-guided Placementl, Radiology, 1992, vol. 185, pp. 803-807.
Ignotus, et al., Review of Radiological Insertion of Indwelling Central Venous Catheters, Minimally Invasive Therapy, 1992, 1:373-388.
Instructions for Use (Copyright Dated 1990) for Polycath Polyurethance Central Venous Catheter; believed to have been packaged with product and sold in the United States before Jan. 4, 2000 and with related marketing materials.
Instructions for Use (Copyright Dated 1992) for FloLock Single Lumen Bi-directional Valved Catheter; believed to have been packaged with product and sold in the United States before Jan. 2000.
Instructions for Use (not dated) for Infuse-a-Cath Polyurethance Central Venous Catheter; believed to have been packaged with product and sold in the United States before Jan. 2000.
Instructions for Use for Diatek Cannon Catheter Product First Sold in the United States in Sep. 2001.
Jones, et al., Efficacy of the Supraclavicular Route for Temporary Hemodialysis Access, Southern Medical Journal, 1992, vol. 85, No. 7, pp. 725-726.
JP 2010-532299 filed Apr. 30, 2010 Official Action dated Apr. 23, 2012.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Decision of Refusal mailed Dec. 24, 2009.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed May 28, 2009.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed Nov. 7, 2008.
Kapoian et al. Dialysis as Treatment of End-Stage Renal Disease, Chapter 5: Dialysis Access and Recirculation, © 1999.
Kaupke, et al., Perforation of the Superior Vena Cava by a Subclavian Hemodialysis Catheter: early detection by angiography, The International Journal of Artificial Organs, 1992, vol. 15, No. 11, pp. 666-668.
Kelber, et al., Factors Affecting Delivery of High-Efficiency Dialysis Using Temporary Vascular Access, American Journal of Kidney Diseases, 1993, vol. 22, No. 1, pp. 24-29.
Lumsden, et al., Hemodialysis Access in the Pediatric Patient Population, The American Journal of Surgery, 1994, vol. 168, pp. 197.
Lund, “Percutaneous Translumbar Inferior Vena Cava Cannulation and other Alternative Vascular Access Techniques” in Venous Interventional Radiology with Clinical Perspectives, Savader et al, eds. pp. 251-61, Apr. 10, 2000.
Lund, et al., Percutaneous Translumbar Inferior Vena Cava Cannulation for Hemodialysis, American Journal of Kidney Diseases, 1995, vol. 25, No. 5, pp. 732-737.
Maki, D., Pathogenesis, Prevention, and Management of Infections Due to Intravascular Devices Used for Infusion Therapy, in Infections Associated with Indwelling Medical Devices, Bisno et al, eds, American Society for Microbiology, 1989, pp. 161-177.
Malviya et al., “Vascular Access in Gynecological Cancer Using the Groshong Right Atrial Catheter”, Gynecological Oncology.
Mauro, et al., Radiologic Placement of Long-term Central Venous Catheters: A Review, JVIR, 1993, vol. 4, No. 1, pp. 127-137.
McGee, et al, Accurate placement of central venous catheters: A prospective, randomized, multicenter trial, Critical Care Medicine, 1993, vol. 21, No. 8, pp. 1118-1123.
Medcomp, For Access via the Internal Jugular Vein . . . The Medcomp TESIO Catheter is the Solution: The Short and Long Term Solution to Subclavian Venin Stenosis and Difficult Access Problems, Brochure, 4 pages, 1991.
Medcomp® Brochure , “Ash Split Cath™ XL”, Dec. 2001, PN 2291.
Medcomp® Brochure , “Ash Split Cath™”, Guidewire Weave Insertion Technique, Jan. 2002, PN 2296.
Medcomp® Brochure , “Ash Split Cath™”, Jul. 2001, PN 2114.
Medcomp® Brochure , “Ash Split Cath™”, Nov. 1997, PN 2050.
Medcomp® Brochure , “Ash Split Cath® II ”, Aug. 2002, PN 2334.
Medcomp® Brochure , “Magna™ High Flow Catheter”, Mar. 2002, PN 2321.
Moss et al, Use of Silicone Dual-Lumen Catheter with a Dacron Cuff as a Long Term Vascular Access for Hemodialysis Patients, Amer J Kidney Diseases, vol. XVI, No. 3, pp. 211-215, Sep. 1990.
Moss, et al., Use of a Silicone Catheter With a Dacron Cuff for Dialysis Short-Term Vascular Access, American Journal of Kidney Diseases, 1988, vol. XII, No. 6, pp. 492-498.
Myers, R.D. et al, New Double-lumen Polyethylene Cannula for Push-pull Perfusion of Brain Tissue in Vivo, Journal of Neuroscience Methods, pp. 205-218, vol. 12, 1985.
Northsea, C., Using Urokinase to Restore Patency in Double Lumen Catheters, ANNA Journal 1994, vol. 21, No. 5, pp. 261-273.
OriGen, OriGen Biomedical Dual Lumen Catheter, from <http://origen.neticatheter.html>, downloaded May 13, 2009, 4 pages (reprinted for submission on Jul. 21, 2011).
Parsa, et al., Establishment of Intravenous Lines for Long-term Intravenous Therapy and Monitoring, Surgical Clinics of N. Am. 1985, vol. 65, No. 4, pp. 835-865.
Parsa, et al., Vascular Access Techniques, Textbook of Critical Care, W.B. Saunders, Philadelphia, PA (1989), pp. 122-127.
Pasquale, et al., Groshong® Versus Hickman® Catheters, Surgery, Gynecology & Obstetrics, 1992, vol. 174, pp. 408-410.
Passaro, et al., Long-term Silastic Catheters and Chest Pain, Journal of Parenteral and Enteral Nutrition, 1994, vol. 18, No. 3, pp. 240-242.
Patel et al., “Sheathless Technique of Ash Split-Cath Insertion”, 12 JVIR 376-78 (Mar. 2001).
Paulsen, et al., Use of Tissue Plasminogen Activator for Reopening of Clotted Dialysis Catheters, Nephron, 1993, vol. 64, pp. 468-470.
PCT/US2003/003751 filed Feb. 7, 2003 Preliminary Examination Report dated May 5, 2004.
PCT/US2003/003751 filed Feb. 7, 2003 Search Report dated Jul. 3, 2003.
PCT/US2004/005102 filed Feb. 19, 2004 Preliminary Report Patenability dated Aug. 29, 2005.
PCT/US2004/005102 filed Feb. 19, 2004 Search Report dated Dec. 27, 2004.
PCT/US2004/005102 filed Feb. 19, 2004 Written Opinion dated Aug. 21, 2005.
PCT/US2008/078551 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010.
PCT/US2008/078551 filed Oct. 2, 2008 Search Report dated Mar. 13, 2009.
PCT/US2008/078551 filed Oct. 2, 2008 Written Opinion dated Mar. 13, 2009.
PCT/US2008/078560 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010.
Arrow Cannon II Plus Brochure, 2006.
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Dr. Karim Valji (Jul. 17, 2008).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Kenneth Todd Cassidy (Jul. 16, 2008).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Rebecca R. Eisenberg in Opposition to Defendant's Motion for Partial Summary Judgment of Invalidity (Jun. 8, 2009).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal].
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity Exhibit a (Jul. 10, 2009).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Plaintiffs Memorandum in Opposition to Defendant's Motion for Summary Judgement on Non-Infringement (Jul. 17, 2008).
Arrow International, Inc. et al. v. Spire Biomedical, Inc., U.S. Dist. Ct. Dist. MA CA No. 06-CV-11564-DPW, Defendant's Omnibus Statement of Material Facts in Support of its Motions for Summary Judgment (Jun. 10, 2008) [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal].
Bander, et al., Central Venous Angioaccess for Hemodialysis and Its Complications, Seminars in Dialysis, 1992, vol. 5, No. 2, pp. 121-128.
Baranowski, L., Central Venous Access Devices, Journal of Intravenous Nursing, 1993, vol. 16, No. 3, pp. 167-194.
Bard Access Systems Hickman@ , Leonard@ , and Broviac® Central Venous Catheters (Long Term), Instructions for Use, 31 pages, 1999.
Bard Access Systems Hickman@ , Leonard@ , and Broviac® Central Venous Catheters, Nursing Procedural Manual, 52 pages, Jun. 1994.
Bard Davol® Hickman® Round Dual Lumen Catheters for Central Venous Access Informational Brochure, 4 pages, 1994.
Bard Hickman® Catheters Informational Brochure, 3 pages, 1994.
Believed to be an unpublished sketch of a conception by Dr. John Frusha; date of sketch believed to be Jun. 24, 1997.
Berkoben, et al., Maintenance of Permanent Hemodialysis Vascular Access Patency, ANNA Journal, 1995, vol. 22, No. 1, pp. 17-24.
Bolz, et al., Catheter Malfunction and Thrombus Formation on Double-Lumen Hemodialysis Catheters: An Intravascular Ultrasonographic Study, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 597-602.
Bour, et al., Experience With the Double Lumen Silastic® Catheter for Hemoaccess, Surgery, Gynecology & Obstetrics, 1990, vol. 171, pp. 33-39.
Camp, “Care of the Groshong Catheter”, Oncol Nurs Forum, vol. 15, No. 6, 1988.
Campbell, et al., Radiological Insertion of Long-term Venous Access Devices, Seminars in Interventional Radiology, 1994, vol. II, No. 4, pp. 366-375.
Canaud, B et al, Permenant Twin Catheter: A Vascular Access Option of Choice for Haemodialysis in Elderly Patients, pp. 82-88, vol. 17 No. 7, 1994.
Claim Construction Order of Federal District Court dated May 9, 2003 in Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc. litigation (S.D. N.Y. 03 Civ.0972).
Claim Construction Order of Federal District Court dated Oct. 31, 2006 in Arrow Int'l Inc.and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation (D. Mass. Civil Action No. 06-CV-11564).
CN 200880121182.0 filed Oct. 20, 2008 First Office Action dated May 2, 2012.
CN 200880121183.5 filed Oct. 2, 2008 First Office Action dated Mar. 28, 2012.
CN 200880121183.5 filed Oct. 2, 2008 Second Office Action dated Aug. 17, 2012.
CN 200880121183.5 filed Oct. 2, 2008 Third Office Action dated Dec. 11, 2012.
CN 200880123095.9 filed Oct. 20, 2008 First Office Action dated Feb. 13, 2012.
CN 200880123095.9 filed Oct. 20, 2008 Second Office Action dated Dec. 18, 2012.
CN 200880123533.1 filed Jun. 30, 2008 First Office Action dated May 28, 2012.
CN 200880123533.1 filed Jun. 30, 2008 Notice of Grant dated Dec. 24, 2012.
Declaration of Gregory S. Haas (Plaintiff's Exhibit 88 in Haas Deposition), Mar. 13, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Defendant's Exhibits DX78-DX114, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.), 2003.
Defendants' Reponses and Objections to Plaintiffs' Second Set of Interrogatories (Excerpt), Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.) (Oct. 8, 2003).
Delmore et al., “Experience with the Groshong Long-Term Central Venous Catheter”, Gynecologic Oncology 34, 216-218 (1989).
Dialysis Vascular Access, SchonXL® Temporary Dialysis (AngioDynamics Inc.) brochure, Nov. 1998.
Dialysis Vascular Access, Technological Innovations Improving Flow (AngioDynamics Inc.) Brochure, 4 pages, Nov. 1998.
Difiore, “Central Venous Dialysis Catheter Evaluatio in Swine”, Journal of Vascular Access Devices, Fall 2000.
Donaldson, et al., Peripherally Inserted Central Venous Catheters: US-guided Vascular Access in Pediatric Patientsl, Radiology, 1995, vol. 197, pp. 542-544.
Dunea, et. al., A Survey of Permanent Double Lumen Catheters in Hemodialysis Patients. Asaio Transac. 1991; 37: M276-7.
Dupont et al, Long-term development of Permacath Quinton catheters used as a vascular access route for extra-renal detoxification; Néphrologie, vol. 15, pp. 105-110, 1994.
EP 04712925.9 filed Feb. 19, 2004 Office Action dated Nov. 7, 2008.
EP 08839196.6 filed Oct. 2, 2008 Examination Report dated Jan. 16, 2013.
EP 08839196.6 filed Oct. 2, 2008 Search Opinion dated Jul. 12, 2011.
EP 08839196.6 filed Oct. 2, 2008 Search Report dated Jul. 12, 2011.
EP 08872340.8 filed Oct. 2, 2008 Extended European Search Report and an Opinion dated Apr. 19, 2012.
Gallichio, et al., Placement of a Double Lumen Silastic Catheter for Hemodialysis Access Through the Cephalic Vein, Journal of the American College of Surgeons, 1994, vol. 179, pp. 171-172.
Gravenstein, et al., In Vitro Evaluation of Relative Perforating Potential of Central Venous Catheters: Comparison of Materials, Selected Models, Number of Lumens, and Angles of Incidence to Simulated Membrane, Journal of Clinical Monitoring, 1991, vol. 7, pp. 1-6.
Haindl, H., Technical complications of port-catheter systems, Reg. Cancer Treat, 1989, 2:238-242.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Jan. 7, 2008.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Jun. 16, 2009.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Nov. 13, 2008.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Nov. 23, 2009.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Advisory Action dated Feb. 19, 2009.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Jul. 15, 2008.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Jul. 7, 2010.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Mar. 18, 2014.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Aug. 1, 2013.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Aug. 18, 2011.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Dec. 30, 2009.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Feb. 2, 2011.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Jul. 23, 2009.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated May 23, 2006.
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated May 24, 2007.
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Final Office Action dated Sep. 1, 2009.
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Feb. 5, 2009.
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Mar. 30, 2011.
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Jun. 25, 2008.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Decision on Appeal dated Dec. 26, 2012.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Examiners Answer dated Apr. 28, 2010.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Final Office Action dated Jul. 22, 2009.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jan. 6, 2009.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jul. 12, 2013.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jul. 9, 2008.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Notice of Allowance dated Apr. 18, 2014.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Examiner's Answer dated Feb. 9, 2012.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Final Office Action dated Jan. 20, 2011.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated Jan. 7, 2010.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated Jul. 7, 2010.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated May 12, 2009.
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Final Office Action dated Jun. 19, 2012.
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Non-Final Office Action dated Jan. 17, 2012.
U.S. Appl. No. 12/244,559 filed Oct. 2, 2008 Examiners Answer dated Mar. 27, 2013.
U.S. Appl. No. 12/244,559 filed Oct. 2, 2009 Final Office Action dated Jul. 3, 2012.
U.S. Appl. No. 12/244,559 filed Oct. 2, 2009 Non-Final Office Action dated Mar. 14, 2012.
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Advisory Action dated Sep. 5, 2012.
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011.
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Non-Final Office Action dated Jan. 19, 2011.
U.S. Appl. No. 12/244,544 filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011.
U.S. Appl. No. 12/244,544 filed Oct. 2, 2008 Non-Final Office Action dated Dec. 22, 2010.
U.S. Appl. No. 12/244,554 filed Oct. 2, 2008 Final Office Action dated Dec. 27, 2010.
U.S. Appl. No. 12/244,554 filed Oct. 2, 2008 Non-Final Office Action dated Jul. 6, 2010.
U.S. Appl. No. 12/253,870 filed Oct. 17, 2008 Non-Final Office Action dated Jan. 21, 2011.
U.S. Appl. No. 12/253,870 filed Oct. 17, 2008 Notice of Allowance dated Aug. 19, 2011.
U.S. Appl. No. 12/262,820 filed Oct. 31, 2008 Non-Final Office Action dated Feb. 18, 2011.
U.S. Appl. No. 12/262,820 filed Oct. 31, 2008 Notice of Allowance dated Sep. 28, 2011.
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Advisory Action dated Aug. 17, 2011.
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Final Office Action dated May 26, 2011.
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Non-Final Office Action dated Jan. 5, 2011.
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Final Office Action dated Feb. 7, 2012.
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Notice of Allowance dated May 31, 2012.
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Non-Final Office Action dated Aug. 11, 2011.
U.S. Appl. No. 13/294,941 filed Nov. 11, 2011 Non-Final Office Action dated May 31, 2013.
U.S. Appl. No. 13/294,941 filed Nov. 11, 2011 Notice of Allowance dated Nov. 27, 2013.
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Advisory Action dated Aug. 8, 2013.
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Final Office Action dated May 30, 2013.
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Non-Final Office Action dated Jan. 2, 2013.
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Notice of Allowance dated Oct. 18, 2013.
US Patent File History U.S. Pat. No. 5,403,291 (Abrahamson), issued Apr. 4, 1995.
US Patent File History U.S. Pat. No. 5,489,278 (Abrahamson), issued Feb. 6, 1996.
US Patent File History U.S. Pat. No. 5,685,867 (Twardowski et al.), issued Nov. 11, 1997.
Wechsler, et al., Thrombosis and Infection Caused by Thoracic Venous Catheters: Pathogenesis and Imagings Findings, AJR, 1993; 160:467-471.
Weitzel, et al, Successful Use of Indwelling Cuffed Femoral Vein Catheters in Ambulatory Hemodialysis Patients, American Journal of Kidney Diseases, 1993, vol. 22, No. 3, pp. 426-429.
PCT/US2008/078560 filed Oct. 2, 2008 Search Report dated Mar. 16, 2009.
PCT/US2008/078560 filed Oct. 2, 2008 Written Opinion dated Mar. 16, 2009.
PCT/US2008/078566 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010.
PCT/US2008/078566 filed Oct. 2, 2008 Search Report dated Mar. 19, 2009.
PCT/US2008/078566 filed Oct. 2, 2008 Written Opinion dated Mar. 19, 2009.
PCT/US2008/078571 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010.
PCT/US2008/078571 filed Oct. 2, 2008 Search Report dated Mar. 20, 2009.
PCT/US2008/078571 filed Oct. 2, 2008 Written Opinion dated Mar. 20, 2009.
PCT/US2008/080463 filed Oct. 20, 2008 Preliminary Report on Patentability dated Apr. 27, 2010.
PCT/US2008/080463 filed Oct. 20, 2008 Search Report dated Mar. 16, 2009.
PCT/US2008/080463 filed Oct. 20, 2008 Written Opinion dated Apr. 16, 2009.
PCT/US2008/082106 filed Oct. 31, 2008 International Preliminary Report on Patentability dated May 4, 2010.
PCT/US2008/082106 filed Oct. 31, 2008 Search Report dated Jan. 12, 2009.
PCT/US2008/082106 filed Oct. 31, 2008 Written Opinion dated Jan. 12, 2009.
Picture of Device believed to be partial sample of a product believed to have been sold in the United States with Polycath and/or Infuse-a-Cath Instructions for Use, 1 page, 2011.
Quinton® Catheter Products (1993).
Raaf Dual Lumen Right Atrial Catheters Brochure—Quinton Instrument Co., 6 pages, 1993.
Raaf, et al., Open Insertion of Right Atrial Catheters Through the Jugular Veins, Surgery, Gynecology & Obstetrics, 1993, vol. 177, pp. 295-298.
Rawn, et al., The Hemodialysis Access, Chapter 9, pp. 9.1-9.11, available at <<http://msl1.mit.edu/ESD10/kidneys/HndbkPDF/Chap09.pdf>>, last accessed Jun. 4, 2012.
Schwab, et al., Prospective Evaluation of a Dacron Cuffed Hemodialysis Catheter for Prolonged Use, American Journal of Kidney Diseases, 1988, vol. XI, No. 2, pp. 166-169.
Schwab, et al., Vascular Access: Case Oriented Discussions of Selected Critical Issues: Hemodialysis Catheters for Permanent Use, 1999.
Shaffer, D., Catheter-Related Sepsis Complicating Long-Term Tunnelled Central Venous Dialysis Catheters: Management by Guidewire Exchange, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 593-596.
Shaffer, D., Lessons From Vascular Access Procedures for Hemodialysis, Surgical Oncology Clinics of North America, 1995, vol. 4, No. 3, pp. 537-549.
Sioshansi, P., New Processes for Surface Treatment of Catheters, Artificial Organs, 1994, 18(4):266-271.
Swartz, et al., Successful Use of Cuffed Centrol Venous Hemodialysis Catheters Inserted Percutaneously, J. Am. Soc. Nephrol., 1994, 4:1719-1725.
Tal, Michael G, Comparison of Recirculation Percentage of the Palindrome Catheter and Standard Hemodialysis Catheters in a Swine Model, J Vasc Intery Radiol, pp. 1237-1240, vol. 16, No. 9, 2005.
Tesio, et al., Double Catheterization of the Internal Jugular Vein for Hemodialysis: Indications, Techniques, and Clinical Results, Artificial Organs, 1994, vol. 18, No. 4, pp. 301-304.
The Groshong™ Peripherally Inserted Central Venous Catheter Brochure—Cath-tech®, 4 pages, 1988.
Transcript of Videotaped Deposition of Gregory Haas (Excerpt), Sep. 23, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-Cv-0972 (S.D.N.Y.).
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 1, Oct. 16, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 2, Oct. 17, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Treiman, et al., Chronic Venous Access in Patients with Cancer, Cancer, 1993, vol. 72, No. 3, pp. 760-765.
Twardowski et al. “Side Holes at the Tip of Chronic Hemodialysis Catehters are Harmful,” The Journal of Vascular Access 2001; 2:8-16.
Twardowski et al., “Blood Recirculation in Intravenous Catheters for Hemodialysis” J. Am. Soc. Nephrol. 3:1978-81 (1993).
Tyco Healthcare, Mahurkar Dual Lumen Catheters, Informational Brochure, 2 pages, 2004.
Tyco Healthcare, Mahurkar QPlus High Flow Acute Care Catheter, Informational Brochure, 2 pages, 2004.
Tyco Healthcare, Tal Palindrome™ Dual Lumen Catheters Order Information, Features and Benefits, Frequently Asked Questions, printed from http://www.kendallvasculartherapy.com/VascularTherapy, 6 pages, on Mar. 1, 2007.
Uldall, P., Subclavian Cannulation Is No Longer Necessary or Justified in Patients with End-Stage Renal Failure, Seminars in Dialysis, 1994, vol. 7, No. 3, pp. 161-164.
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Final Office Action dated Jan. 19, 2007.
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Final Office Action dated Mar. 7, 2007.
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Non-Final Office Action dated Jul. 17, 2006.
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Notice of Allowance dated Jun. 1, 2007.
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated Apr. 13, 2007.
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated Dec. 12, 2008.
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated May 30, 2008.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Advisory Action dated Oct. 9, 2008.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Final Office Action dated Jul. 29, 2008.
U.S. Appl. No. 10/842,586 filed May 10, 2004 Final Office Action dated May 25, 2010.
CN 201310073124.8 filed Mar. 7, 2013 First Office Action dated May 5, 2014.
JP 2010-532299 filed Apr. 30, 2010 Final Notice of Reason for Rejection dated Feb. 8, 2013.
PCT/US2014/066811 filed Nov. 21, 2014 International Search Report and Written Opinion dated Apr. 15, 2015.
Septum, Wikipedia, The Free Encyclopedia, hhtp://en.wikipedia.org/wiki/Septum (last visited Dec. 18, 2012) (defining “septum” as “a wall, dividing a cavity or structure into smaller ones”).
Taber's Cyclopedic Medical Dictionary 1662 (16th ed. 1989) (defining “septum” as a “wall dividing two cavities”).
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Jul. 9, 2014.
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Decision on Appeal dated Feb. 2, 2015.
U.S. Appl. No. 13/329,156 filed Dec. 16, 2011 Non-Final Office Action dated May 16, 2014.
U.S. Appl. No. 13/897,292 filed May 17, 2013 Final Office Action dated Apr. 9, 2015.
U.S. Appl. No. 13/897,292 filed May 17, 2013 Non-Final Office Action dated Nov. 20, 2014.
U.S. Appl. No. 14/032,858 filed Sep. 20, 2013 Final Office Action dated Mar. 31, 2015.
U.S. Appl. No. 14/032,858 filed Sep. 20, 2013 Non-Final Office Action dated Nov. 4, 2014.
U.S. Appl. No. 14/252,567 filed Apr. 14, 2014 Non-Final Office Action dated Mar. 31, 2015.
U.S. Appl. No. 14/094,534, filed Dec. 2, 2013 Non-Final Office Action dated Feb. 24, 2016.
Related Publications (1)
Number Date Country
20140330220 A1 Nov 2014 US
Continuations (2)
Number Date Country
Parent 11874447 Oct 2007 US
Child 14328541 US
Parent 10371774 Feb 2003 US
Child 11874447 US